
    
<!DOCTYPE html>




<html lang="en" >
<head >
    <meta charset="UTF-8">
    <meta http-equiv="X-UA-Compatible" content="IE=edge">

    <!-- Mobile properties -->
    <meta name="HandheldFriendly" content="True">
    <meta name="MobileOptimized" content="320">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">

  
    <!-- Stylesheets -->
    <link rel="stylesheet" href="/pmc/static/CACHE/css/output.cc84172e9e16.css" type="text/css">
  
  <link rel="stylesheet" href="/pmc/static/CACHE/css/output.b634933a977d.css" type="text/css"><link rel="stylesheet" href="/pmc/static/CACHE/css/output.913c7dcab8ff.css" type="text/css"><link rel="stylesheet" href="/pmc/static/CACHE/css/output.3766d7ad0d2d.css" type="text/css"><link rel="stylesheet" href="/pmc/static/CACHE/css/output.e3c3c2c84eb3.css" type="text/css">

  
    <link rel="stylesheet" href="https://maxcdn.bootstrapcdn.com/font-awesome/4.7.0/css/font-awesome.min.css"/>
  
<link type="text/css" href="/pmc/static/bundles/base/base.a2ef7ca69e4b20dff539.css" rel="stylesheet" />


    <link rel="stylesheet" href="/corehtml/pmc/css/fonts/stix/stixfonts.css" type="text/css" /><link rel="stylesheet" href="/corehtml/pmc/css/3.18/pmcrefs5.min.css" type="text/css" /><link rel="stylesheet" href="/corehtml/pmc/css/pmc2020_1.1/ncbi_web.min.css?_=a" type="text/css" /><style type="text/css">.pmc-wm {background:transparent repeat-y top left;background-image:url(/corehtml/pmc/pmcgifs/wm-journal.gif);background-size: auto, contain}</style><style type="text/css">.print-view{display:block}</style>

    <link type="text/css" href="/pmc/static/bundles/article/article.3c5d12ff2e4beea20136.css" rel="stylesheet" />
    <link type="text/css" href="/pmc/static/django_pmc_cite_box/lib/cite-box.css" rel="stylesheet" />


    <title>RRM2 is a potential prognostic biomarker with functional significance in glioma - PMC</title>

  
  <!-- Favicons -->
  <link rel="shortcut icon" type="image/ico" href="https://www.ncbi.nlm.nih.gov/coreutils/nwds/img/favicons/favicon.ico" />
  <link rel="icon" type="image/png" href="https://www.ncbi.nlm.nih.gov/coreutils/nwds/img/favicons/favicon.png" />

  <!-- 192x192, as recommended for Android
  http://updates.html5rocks.com/2014/11/Support-for-theme-color-in-Chrome-39-for-Android
  -->
  <link rel="icon" type="image/png" sizes="192x192" href="https://www.ncbi.nlm.nih.gov/coreutils/nwds/img/favicons/favicon-192.png" />

  <!-- 57x57 (precomposed) for iPhone 3GS, pre-2011 iPod Touch and older Android devices -->
  <link rel="apple-touch-icon-precomposed" href="https://www.ncbi.nlm.nih.gov/coreutils/nwds/img/favicons/favicon-57.png">
  <!-- 72x72 (precomposed) for 1st generation iPad, iPad 2 and iPad mini -->
  <link rel="apple-touch-icon-precomposed" sizes="72x72" href="https://www.ncbi.nlm.nih.gov/coreutils/nwds/img/favicons/favicon-72.png">
  <!-- 114x114 (precomposed) for iPhone 4, 4S, 5 and post-2011 iPod Touch -->
  <link rel="apple-touch-icon-precomposed" sizes="114x114" href="https://www.ncbi.nlm.nih.gov/coreutils/nwds/img/favicons/favicon-114.png">
  <!-- 144x144 (precomposed) for iPad 3rd and 4th generation -->
  <link rel="apple-touch-icon-precomposed" sizes="144x144" href="https://www.ncbi.nlm.nih.gov/coreutils/nwds/img/favicons/favicon-144.png">



    
        <!-- Logging params: Pinger defaults -->

<meta name="ncbi_app" content="pmc-frontend" />

<meta name="ncbi_db" content="pmc" />

<meta name="ncbi_phid" content="D0BD41E4AC192A45000042A14F3E9EF8.1.m_2" />


        <!-- Logging params: Pinger custom -->

<meta name="ncbi_pdid" content="article" />

<meta name="ncbi_op" content="retrieved" />

<meta name="ncbi_app_version" content="0.0" />

<meta name="ncbi_domain" content="ijbiosci" />

<meta name="ncbi_type" content="fulltext" />

<meta name="ncbi_pcid" content="/articles/PMC6367584/" />


    


    <script>
        
            var ncbiBaseUrl = "https://www.ncbi.nlm.nih.gov";
        
        var useOfficialGovtHeader = true;
    </script>


    <meta name="robots" content="INDEX,NOFOLLOW,NOARCHIVE" /><link rel="canonical" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6367584/" /><link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /><meta name="citation_journal_title" content="International Journal of Biological Sciences" /><meta name="citation_title" content="RRM2 is a potential prognostic biomarker with functional significance in glioma" /><meta name="citation_author" content="Hongzhi Sun" /><meta name="citation_author_institution" content="Department of Pathogen Biology, Nanjing Medical University, Nanjing, Jiangsu, 211166, China." /><meta name="citation_author" content="Bingya Yang" /><meta name="citation_author_institution" content="Department of Pathogen Biology, Nanjing Medical University, Nanjing, Jiangsu, 211166, China." /><meta name="citation_author_institution" content="Jiangsu Province Key Laboratory of Modern Pathogen Biology, Nanjing, Jiangsu, 211166, China." /><meta name="citation_author" content="Hao Zhang" /><meta name="citation_author_institution" content="Department of Pathogen Biology, Nanjing Medical University, Nanjing, Jiangsu, 211166, China." /><meta name="citation_author" content="Jingwei Song" /><meta name="citation_author_institution" content="Department of Pathogen Biology, Nanjing Medical University, Nanjing, Jiangsu, 211166, China." /><meta name="citation_author" content="Yenan Zhang" /><meta name="citation_author_institution" content="Department of Pathogen Biology, Nanjing Medical University, Nanjing, Jiangsu, 211166, China." /><meta name="citation_author" content="Jicheng Xing" /><meta name="citation_author_institution" content="Department of Clinical laboratory, Bayi Hospital Affiliated to Nanjing University Of Chinese Medicine, Nanjing, Jiangsu, 210002, China." /><meta name="citation_author" content="Zhihui Yang" /><meta name="citation_author_institution" content="Department of Clinical laboratory, Bayi Hospital Affiliated to Nanjing University Of Chinese Medicine, Nanjing, Jiangsu, 210002, China." /><meta name="citation_author" content="Changyong Wei" /><meta name="citation_author_institution" content="Department of Hematology and Medical Oncology, School of Medicine, Emory University, Atlanta, GA 30322, USA." /><meta name="citation_author" content="Tuoye Xu" /><meta name="citation_author_institution" content="Department of Neurosurgery, Brain Hospital, affiliated to Nanjing medical University, Nanjing, 210029, China." /><meta name="citation_author" content="Zhennan Yu" /><meta name="citation_author_institution" content="Department of Neurosurgery, Brain Hospital, affiliated to Nanjing medical University, Nanjing, 210029, China." /><meta name="citation_author" content="Zhipeng Xu" /><meta name="citation_author_institution" content="Department of Pathogen Biology, Nanjing Medical University, Nanjing, Jiangsu, 211166, China." /><meta name="citation_author_institution" content="Jiangsu Province Key Laboratory of Modern Pathogen Biology, Nanjing, Jiangsu, 211166, China." /><meta name="citation_author" content="Min Hou" /><meta name="citation_author_institution" content="Department of Pathogen Biology, Nanjing Medical University, Nanjing, Jiangsu, 211166, China." /><meta name="citation_author" content="Minjun Ji" /><meta name="citation_author_institution" content="Department of Pathogen Biology, Nanjing Medical University, Nanjing, Jiangsu, 211166, China." /><meta name="citation_author_institution" content="Jiangsu Province Key Laboratory of Modern Pathogen Biology, Nanjing, Jiangsu, 211166, China." /><meta name="citation_author" content="Yansong Zhang" /><meta name="citation_author_institution" content="Department of Neurosurgery, Brain Hospital, affiliated to Nanjing medical University, Nanjing, 210029, China." /><meta name="citation_publication_date" content="2019" /><meta name="citation_issue" content="3" /><meta name="citation_volume" content="15" /><meta name="citation_firstpage" content="533" /><meta name="citation_doi" content="10.7150/ijbs.30114" /><meta name="citation_abstract_html_url" content="/pmc/articles/PMC6367584/?report=abstract" /><meta name="citation_fulltext_html_url" content="/pmc/articles/PMC6367584/" /><meta name="citation_pmid" content="30745840" /><meta name="DC.Title" content="RRM2 is a potential prognostic biomarker with functional significance in glioma" /><meta name="DC.Type" content="Text" /><meta name="DC.Publisher" content="Ivyspring International Publisher" /><meta name="DC.Contributor" content="Hongzhi Sun" /><meta name="DC.Contributor" content="Bingya Yang" /><meta name="DC.Contributor" content="Hao Zhang" /><meta name="DC.Contributor" content="Jingwei Song" /><meta name="DC.Contributor" content="Yenan Zhang" /><meta name="DC.Contributor" content="Jicheng Xing" /><meta name="DC.Contributor" content="Zhihui Yang" /><meta name="DC.Contributor" content="Changyong Wei" /><meta name="DC.Contributor" content="Tuoye Xu" /><meta name="DC.Contributor" content="Zhennan Yu" /><meta name="DC.Contributor" content="Zhipeng Xu" /><meta name="DC.Contributor" content="Min Hou" /><meta name="DC.Contributor" content="Minjun Ji" /><meta name="DC.Contributor" content="Yansong Zhang" /><meta name="DC.Date" content="2019" /><meta name="DC.Identifier" content="10.7150/ijbs.30114" /><meta name="DC.Language" content="en" /><meta property="og:title" content="RRM2 is a potential prognostic biomarker with functional significance in glioma" /><meta property="og:type" content="article" /><meta property="og:description" content="Glioma is one of the most common brain tumors, suggesting the importance of investigating the molecular mechanism of gliomas. We studied the roles of Ribonucleotide Reductase Regulatory Subunit M2 (RRM2) in glioma. Expressions of RRM2 are higher in glioma ..." /><meta property="og:url" content="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6367584/" /><meta property="og:site_name" content="PubMed Central (PMC)" /><meta property="og:image" content="https://www.ncbi.nlm.nih.gov/corehtml/pmc/pmcgifs/pmc-card-share.jpg?_=0" /><meta name="twitter:card" content="summary_large_image" /><meta name="twitter:site" content="@ncbi" /><meta name="ncbi_feature" content="associated_data" />


</head>
<body >

   
    
        <button
          class="back-to-top back-to-top--bottom"
          data-ga-category="pagination"
          data-ga-action="back_to_top">
          Back to Top
        </button>
    

    <a class="usa-skipnav" href="#main-content">Skip to main content</a>
    <!-- ========== BEGIN HEADER ========== -->
<section class="usa-banner" style="display: none;">
  <div class="usa-accordion">
    <header class="usa-banner-header">
      <div class="usa-grid usa-banner-inner">
        <img src="https://www.ncbi.nlm.nih.gov/coreutils/uswds/img/favicons/favicon-57.png" alt="U.S. flag" />
        <p>An official website of the United States government</p>
        <button
          class="usa-accordion-button usa-banner-button"
          aria-expanded="false"
          aria-controls="gov-banner-top"
        >
          <span class="usa-banner-button-text">Here's how you know</span>
        </button>
      </div>
    </header>
    <div
      class="usa-banner-content usa-grid usa-accordion-content"
      id="gov-banner-top"
    >
      <div class="usa-banner-guidance-gov usa-width-one-half">
        <img
          class="usa-banner-icon usa-media_block-img"
          src="https://www.ncbi.nlm.nih.gov/coreutils/uswds/img/icon-dot-gov.svg"
          alt="Dot gov"
        />
        <div class="usa-media_block-body">
          <p>
            <strong>The .gov means it’s official.</strong>
            <br />
            Federal government websites often end in .gov or .mil. Before
            sharing sensitive information, make sure you’re on a federal
            government site.
          </p>
        </div>
      </div>
      <div class="usa-banner-guidance-ssl usa-width-one-half">
        <img
          class="usa-banner-icon usa-media_block-img"
          src="https://www.ncbi.nlm.nih.gov/coreutils/uswds/img/icon-https.svg"
          alt="Https"
        />
        <div class="usa-media_block-body">
          <p>
            <strong>The site is secure.</strong>
            <br />
            The <strong>https://</strong> ensures that you are connecting to the
            official website and that any information you provide is encrypted
            and transmitted securely.
          </p>
        </div>
      </div>
    </div>
  </div>
</section>
<div class="usa-overlay"></div>
<header class="ncbi-header" role="banner" data-section="Header">

	<div class="usa-grid">
		<div class="usa-width-one-whole">

            <div class="ncbi-header__logo">
                <a href="https://www.ncbi.nlm.nih.gov/" class="logo" aria-label="NCBI Logo" data-ga-action="click_image" data-ga-label="NIH NLM Logo">
                  <img src="https://www.ncbi.nlm.nih.gov/coreutils/nwds/img/logos/AgencyLogo.svg" alt="NIH NLM Logo" />
                </a>
            </div>

			<div class="ncbi-header__account">
				<a id="account_login" href="https://account.ncbi.nlm.nih.gov" class="usa-button header-button" style="display:none" data-ga-action="open_menu" data-ga-label="account_menu">Log in</a>
				<button id="account_info" class="header-button" style="display:none"
						aria-controls="account_popup">
					<span class="fa fa-user" aria-hidden="true"></span>
					<span class="username desktop-only" aria-hidden="true" id="uname_short"></span>
					<span class="sr-only">Show account info</span>
				</button>
			</div>

			<div class="ncbi-popup-anchor">
				<div class="ncbi-popup account-popup" id="account_popup" aria-hidden="true">
					<div class="ncbi-popup-head">
						<button class="ncbi-close-button" data-ga-action="close_menu" data-ga-label="account_menu"><span class="fa fa-times"></span><span class="usa-sr-only">Close</span></button>
						<h4>Account</h4>
					</div>
					<div class="account-user-info">
						Logged in as:<br/>
						<b><span class="username" id="uname_long">username</span></b>
					</div>
					<div class="account-links">
						<ul class="usa-unstyled-list">
							<li><a id="account_myncbi" href="/myncbi/" class="set-base-url" data-ga-action="click_menu_item" data-ga-label="account_myncbi">Dashboard</a></li>
							<li><a id="account_pubs" href="/myncbi/collections/bibliography/" class="set-base-url" data-ga-action="click_menu_item" data-ga-label="account_pubs">Publications</a></li>
							<li><a id="account_settings" href="/account/settings/" class="set-base-url" data-ga-action="click_menu_item" data-ga-label="account_settings">Account settings</a></li>
							<li><a id="account_logout" href="/account/signout/" class="set-base-url" data-ga-action="click_menu_item" data-ga-label="account_logout">Log out</a></li>
						</ul>
					</div>
				</div>
			</div>

		</div>
	</div>
</header>
<div role="navigation" aria-label="access keys">
<a id="nws_header_accesskey_0" href="https://www.ncbi.nlm.nih.gov/guide/browsers/#ncbi_accesskeys" class="usa-sr-only" accesskey="0" tabindex="-1">Access keys</a>
<a id="nws_header_accesskey_1" href="https://www.ncbi.nlm.nih.gov" class="usa-sr-only" accesskey="1" tabindex="-1">NCBI Homepage</a>
<a id="nws_header_accesskey_2" href="/myncbi/" class="set-base-url usa-sr-only" accesskey="2" tabindex="-1">MyNCBI Homepage</a>
<a id="nws_header_accesskey_3" href="#maincontent" class="usa-sr-only" accesskey="3" tabindex="-1">Main Content</a>
<a id="nws_header_accesskey_4" href="#" class="usa-sr-only" accesskey="4" tabindex="-1">Main Navigation</a>
</div>
<section data-section="Alerts">
	<div class="ncbi-alerts-placeholder"></div>
</section>
<!-- ========== END HEADER ========== -->

    
    


    
        

<section class="pmc-alerts">
    
    <div role="alert" class="pmc-alert pmc-alert--info" role="region" aria-label="Alert" aria-hidden="false"  data-key="pmc-alert-welcome">
        <div class="pmc-alert__body pmc-alert--ncbi-icon">
            <div class="pmc-alert__content">
                <p>
                    <strong>
                        Preview improvements coming to the PMC website in October 2024.
                        <a href="https://ncbiinsights.ncbi.nlm.nih.gov/2024/03/14/preview-pmc-improvements/" data-ga-category="cloud_beta_banner" data-ga-label="learn_more" data-ga-action="on_pmc2020">Learn More</a> or
                        <a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC6367584/" data-ga-category="cloud_beta_banner" data-ga-action="on_pmc2020" data-ga-label="go_to_cloud">Try it out now</a>.
                    </strong>
                </p>
            </div>
        </div>
    </div>
    
</section>
    

    
    
        
        <header class="pmc-header usa-header-extended" role="banner">
    <div class="pmc-header__bar">
        <div class="pmc-header__control usa-accordion">
            
                <button class="usa-menu-btn pmc-header--button pmc-header--left">
                    <i class="fa fa-ellipsis-v" aria-hidden="true"></i>
                </button>
            

            <div class="usa-logo pmc-header__logo pmc-header--stretch
                
               " id="extended-mega-logo">
                <div class="usa-logo-text">
                    <a href="/pmc/" title="Home" aria-label="Home" ></a>
                </div>
            </div>
            <button class="usa-accordion-button pmc-header--right pmc-header--button pmc-header__search--control pmc-header--right" aria-expanded="false" aria-controls="a1">
                <i class="fa fa-search" aria-hidden="true"></i>
                <i class="fa fa-times" aria-hidden="true"></i>
            </button>
        </div>
        <div class="pmc-header__search usa-accordion-content" id="a1">
            <div role="search"  class="pmc-header--stretch"  >
    <form class="usa-search " autocomplete="off">
        <div>
              <label class="usa-sr-only" for="pmc-search">Search PMC Full-Text Archive</label>
              <span class="clearable">
                <input
                  required="required"
                  autocomplete-url="/pmc/autocomplete/pmc/"
                  placeholder="Search PMC Full-Text Archive"
                  id="pmc-search" type="search" name="term"/>
                  <i class="clear-btn" ></i>
              </span>
              <button type="submit" formaction="/pmc/">
                <span class="usa-search-submit-text">Search in PMC</span>
              </button>
        </div>
    </form>
</div>


            <ul class="usa-unstyled-list usa-nav-secondary-links pmc-header--offset-two">
                    <li>
                        <a href="https://www.ncbi.nlm.nih.gov/pmc/advanced" data-ga-action="featured_link" data-ga-label="advanced_search">
                            Advanced Search
                        </a>
                    </li>
                    <li>
                        <a  href="/pmc/about/userguide/" data-ga-action="featured_link"
                        data-ga-label="user guide">
                            User Guide
                        </a>
                    </li>
            </ul>
        </div>
    </div>
     <nav role="navigation" class="usa-nav ">
        <button class="usa-nav-close">
            <i class="fa fa-times" aria-hidden="true"></i>
        </button>
        <div class="usa-breadcrumb usa-breadcrumb--wrap usa-breadcrumb--hack">
             
    <ul class="usa-breadcrumb__list">
            
                <li class="usa-breadcrumb__list-item"
                    >
                    <a href="/pmc/journals/" class="navlink">Journal List</a>
                </li>
            
                <li class="usa-breadcrumb__list-item"
                    >
                    <a class="navlink" href="/pmc/journals/294/">Int J Biol Sci</a>
                </li>
            
                <li class="usa-breadcrumb__list-item"
                    >
                    <a class="navlink" href="/pmc/issues/329202/">v.15(3); 2019</a>
                </li>
            
                <li class="usa-breadcrumb__list-item"
                     aria-current="page" >
                    PMC6367584
                </li>
            
    </ul>
 

        </div>
        
        
            <div class="pmc-sidebar pmc-sidebar-hack">
                

<div class="scroller">

    
        <section>
                <h6>Other Formats</h6>
                <ul class="pmc-sidebar__formats">
                  <li class="pdf-link other_item"><a href="/pmc/articles/PMC6367584/pdf/ijbsv15p0533.pdf" class="int-view">PDF (1.8M)</a></li>
                </ul>
        </section>
    
    <section>
        <h6>Actions</h6>
        <ul class="pmc-sidebar__actions">
            <li>
                <button role="button" class="citation-button citation-dialog-trigger ctxp"
                        aria-label="Open dialog with citation text in different styles" data-ga-category="save_share" data-ga-action="cite" data-ga-label="open"
                        data-all-citations-url="/pmc/resources/citations/6367584/"
                        data-citation-style="nlm"
                        data-download-format-link="/pmc/resources/citations/6367584/export/"
                >
                    <span class="button-label">Cite</span>
                </button>
            </li>
            <li>
                
                    

<link type="text/css" href="ncbi-overlay-block/src/overlay-block.css">
<div class="collections-button-container" data-article-id="6367584" data-article-db="pmc">
  <button class="collections-button collections-dialog-trigger"
          aria-label="Save article in MyNCBI collections."
          data-ga-category="collections_button"
          data-ga-action="click"
          data-ga-label="collections_button"
          data-collections-open-dialog-enabled="false"
          data-collections-open-dialog-url="https://www.ncbi.nlm.nih.gov/account?back_url=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC6367584%2F%23open-collections-dialog"
          data-in-collections="false">
      <span class="button-label">Collections</span>
  </button>
  <div class="overlay" role="dialog">
  <div id="collections-action-dialog"
       class="dialog collections-dialog"
       aria-hidden="true">
    <div class="title">Add to Collections</div>
    <div class="collections-action-panel action-panel">
      


<form id="collections-action-dialog-form"
      class="collections-action-panel-form action-panel-content action-form action-panel-smaller-selectors"
      data-existing-collections-url="/pmc/list-existing-collections/"
      data-add-to-existing-collection-url="/pmc/add-to-existing-collection/"
      data-create-and-add-to-new-collection-url="/pmc/create-and-add-to-new-collection/"
      data-myncbi-max-collection-name-length="100"
      data-collections-root-url="https://www.ncbi.nlm.nih.gov/myncbi/collections/">

  <input type="hidden" name="csrfmiddlewaretoken" value="rNdaiLUo8DlrTbJ4cJDGYAdnQ1eOIhfHwS3bihuR3ww3geNBdIasID9A0m3VrDu5">

  

  <div class="choice-group" role="radiogroup">
    <ul class="radio-group-items">
      <li>
        <input type="radio"
               id="collections-action-dialog-new-header "
               class="collections-new"
               name="collections"
               value="new"
               data-ga-category="collections_button"
               data-ga-action="click"
               data-ga-label="collections_radio_new">
        <label for="collections-action-dialog-new-header ">Create a new collection</label>
      </li>
      <li>
        <input type="radio"
               id="collections-action-dialog-existing-header "
               class="collections-existing"
               name="collections"
               value="existing"
               checked="true"
               data-ga-category="collections_button"
               data-ga-action="click"
               data-ga-label="collections_radio_existing">
        <label for="collections-action-dialog-existing-header ">Add to an existing collection</label>
      </li>
    </ul>
  </div>

  <div class="controls-wrapper">
    <div class="action-panel-control-wrap new-collections-controls">
      <label for="collections-action-dialog-add-to-new" class="action-panel-label required-field-asterisk">
        Name your collection:
      </label>
      <input
        type="text"
        name="add-to-new-collection"
        id="collections-action-dialog-add-to-new"
        class="collections-action-add-to-new"
        pattern="[^&quot;&amp;=&lt;&gt;/]*" title="The following characters are not allowed in the Name field: &quot;&amp;=&lt;&gt;/"
        maxlength=""
        data-ga-category="collections_button"
        data-ga-action="create_collection"
        data-ga-label="non_favorties_collection">
      <div class="collections-new-name-too-long usa-input-error-message selection-validation-message">
        Name must be less than  characters
      </div>
    </div>
    <div class="action-panel-control-wrap existing-collections-controls">
      <label for="collections-action-dialog-add-to-existing" class="action-panel-label">
        Choose a collection:
      </label>
      <select id="collections-action-dialog-add-to-existing"
              class="action-panel-selector collections-action-add-to-existing"
              data-ga-category="collections_button"
              data-ga-action="select_collection"
              data-ga-label="($('.collections-action-add-to-existing').val() === 'Favorites') ? 'Favorites' : 'non_favorites_collection'">
      </select>
      <div class="collections-retry-load-on-error usa-input-error-message selection-validation-message">
        Unable to load your collection due to an error<br>
        <a href="#">Please try again</a>
      </div>
    </div>
  </div>

  <div class="action-panel-actions">
    <button class="action-panel-submit"
            type="submit"
            data-loading-label="Adding..."
            data-pinger-ignore
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="add">
      Add
    </button>
    <button class="action-panel-cancel"
            aria-label="Close 'Add to Collections' panel"
            ref="linksrc=close_collections_panel"
            aria-controls="collections-action-panel"
            aria-expanded="false"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="cancel">
      Cancel
    </button>
  </div>
</form>
    </div>
  </div>
</div>
</div>
                
            </li>

        </ul>
    </section>
    
        <section class="social-sharing">
            <h6>Share</h6>
            <ul class="pmc-sidebar__share">
                <li><a class="fa-stack fa-lg" target="_blank" rel="noopener noreferrer" role="button" href="https://twitter.com/intent/tweet?url=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC6367584%2F&amp;text=RRM2%20is%20a%20potential%20prognostic%20biomarker%20with%20functional%20significance%20in%20glioma" alt="Share on Twitter"><i class="fa fa-twitter fa-stack-1x">&#160;</i></a></li> 
<li><a class="fa-stack fa-lg" target="_blank" rel="noopener noreferrer" role="button" href="https://www.facebook.com/sharer/sharer.php?u=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC6367584%2F" alt="Share on Facebook"><i class="fa fa-facebook fa-stack-1x">&#160;</i></a></li>
                <li>
                    <div class="share-permalink">
                        <button class="trigger"  alt="Show article permalink" aria-expanded="false" aria-haspopup="true">
                            <i class="fa-stack fa-lg" >
                                <i class="fa fa-link fa-stack-1x">&nbsp;</i>
                            </i>
                        </button>
                        <div class="dropdown dropdown-container" hidden>
                              <div class="title">
                                Permalink
                              </div>
                              <div class="content">
                                  <input type="text" class="permalink-text" value="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6367584/" aria-label="Article permalink"><button class="permalink-copy-button usa-button-primary" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                                      <span class="button-title">Copy</span>
                                  </button>
                              </div>
                        </div>
                    </div>
                </li>
            </ul>
        </section>
    
    <section>
        <h6>RESOURCES</h6>
        <ul class="pmc-sidebar__resources">
        
            <li>
                <div class="usa-accordion">
                    <button
                            data-ga-category="resources_accordion"
                            data-ga-action="open_similar_articles"
                            data-ga-label="/pmc/articles/PMC6367584/"
                            class="usa-accordion-button"
                            aria-controls="similar-articles-accordion-header"
                            aria-expanded="false"
                            data-action-open="open_similar_articles"
                            data-action-close="close_similar_articles"
                    >
                        Similar articles
                    </button>
                    <div
                            
                                data-source-url="/pmc/resources/similar-article-links/30745840/"
                            

                         class="usa-accordion-content pmc-sidebar__resources--citations" id="similar-articles-accordion-header" aria-hidden="true">
                        
                    </div>
                </div>
            </li>
            <li>
                <div class="usa-accordion">
                    <button
                            data-ga-category="resources_accordion"
                            data-ga-action="open_cited_by"
                            data-ga-label="/pmc/articles/PMC6367584/"
                            class="usa-accordion-button"
                            aria-controls="cited-by-accordion-header"
                            aria-expanded="false"
                            data-action-open="open_cited_by"
                            data-action-close="close_cited_by"
                    >
                        Cited by other articles
                    </button>
                    <div
                            
                                data-source-url="/pmc/resources/cited-by-links/30745840/"
                            
                            class="usa-accordion-content pmc-sidebar__resources--citations"
                            id="cited-by-accordion-header"
                            aria-hidden="true"
                    >
                        
                    </div>
                </div>
            </li>
            <li>
                <div class="usa-accordion">
                    <button
                            data-ga-category="resources_accordion"
                            data-ga-action="open_NCBI_links"
                            data-ga-label="/pmc/articles/PMC6367584/"
                            class="usa-accordion-button"
                            aria-controls="links-accordion-header"
                            aria-expanded="false"
                            data-action-open="open_NCBI_links"
                            data-action-close="close_NCBI_link"
                    >
                        Links to NCBI Databases
                    </button>
                    <div data-source-url="/pmc/resources/db-links/6367584/" class="usa-accordion-content" id="links-accordion-header" aria-hidden="true"></div>
                </div>
            </li>

            
        
        </ul>
    </section>

 </div>
            </div>
        

    </nav>

</header>

    
    

    <div class="usa-overlay"></div>
    
<main id="main-content" class="usa-grid usa-layout-docs pmc-main">
    <article class="usa-width-three-fourths usa-layout-docs-main_content pmc-article">
        <section class="usa-breadcrumb usa-breadcrumb--wrap">
         
    <ul class="usa-breadcrumb__list">
            
                <li class="usa-breadcrumb__list-item"
                    >
                    <a href="/pmc/journals/" class="navlink">Journal List</a>
                </li>
            
                <li class="usa-breadcrumb__list-item"
                    >
                    <a class="navlink" href="/pmc/journals/294/">Int J Biol Sci</a>
                </li>
            
                <li class="usa-breadcrumb__list-item"
                    >
                    <a class="navlink" href="/pmc/issues/329202/">v.15(3); 2019</a>
                </li>
            
                <li class="usa-breadcrumb__list-item"
                     aria-current="page" >
                    PMC6367584
                </li>
            
    </ul>
 

        </section>
        
  <div class="pmc-article__disclaimer" role="complementary" aria-label="Disclaimer note">
    As a library, NLM provides access to scientific literature. Inclusion in an NLM database does not imply endorsement of, or agreement with,
    the contents by NLM or the National Institutes of Health.<br/>
    Learn more:
    <a data-ga-category="Link click" data-ga-action="Disclaimer" data-ga-label="New disclaimer box" href="/pmc/about/disclaimer/">PMC Disclaimer</a>
    |
    <a data-ga-category="Link click" data-ga-action="PMC Copyright Notice" data-ga-label="New disclaimer box" href="/pmc/about/copyright/">
        PMC Copyright Notice
    </a>
</div>

        <section class="pmc-page-banner" role="banner">
            
                
                    <div><img src="/corehtml/pmc/pmcgifs/logo-ijbiosci.gif" alt="Logo of ijbiosci" usemap="#logo-imagemap" /><map id="logo-imagemap" name="logo-imagemap"><area shape="rect" coords="142,57,354,78" href="http://biolsci.org/submission.php" alt="Submit a manuscript" title="Submit a manuscript" target="_blank" rel="noopener noreferrer" /><area shape="rect" coords="2,56,135,76" href="http://biolsci.org" alt="About this journal" title="About this journal" target="_blank" rel="noopener noreferrer" /><area shape="rect" coords="356,52,498,78" href="http://biolsci.org" alt="biolsci.org" target="_blank" rel="noopener noreferrer" /><area shape="default" coord="0,0,499,74" href="http://biolsci.org" alt="International Journal of Biological Sciences" title="International Journal of Biological Sciences" target="_blank" rel="noopener noreferrer" /></map></div> 
                
            
        </section>
        <section  role="document">
            
                <div id="mc" class=" article lit-style content pmc-wm slang-all page-box"><!--main-content--><div class="jig-ncbiinpagenav" data-jigconfig="smoothScroll: false, allHeadingLevels: ['h2'], headingExclude: ':hidden,.nomenu'"><div class="fm-sec half_rhythm no_top_margin"><div class="fm-flexbox"><div class="fm-citation"><div class="citation-default"><div class="part1"><span id="pmcmata">Int J Biol Sci.</span> 2019; 15(3): 533–543. </div><div class="part2"><span class="fm-vol-iss-date">Published online 2019 Jan 1. </span>  <span class="doi"><span>doi: </span><a href="//doi.org/10.7150%2Fijbs.30114" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=6367584&amp;issue-id=329202&amp;journal-id=294&amp;FROM=Article%7CFront%20Matter&amp;TO=Content%20Provider%7CCrosslink%7CDOI">10.7150/ijbs.30114</a></span></div></div></div><div class="fm-ids"><div class="fm-citation-pmcid"><span class="fm-citation-ids-label">PMCID: </span><span>PMC6367584</span></div><div class="fm-citation-pmid">PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/30745840">30745840</a></div></div></div><h1 class="content-title">RRM2 is a potential prognostic biomarker with functional significance in glioma</h1><div class="half_rhythm"><div class="contrib-group fm-author"><a href="https://pubmed.ncbi.nlm.nih.gov/?term=Sun%20H%5BAuthor%5D" class="affpopup" co-rid="_co_idm140460571009680" co-class="co-affbox">Hongzhi Sun</a>,<sup>1,</sup><sup>#</sup> <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Yang%20B%5BAuthor%5D" class="affpopup" co-rid="_co_idm140460571007568" co-class="co-affbox">Bingya Yang</a>,<sup>1,</sup><sup>2,</sup><sup>#</sup> <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Zhang%20H%5BAuthor%5D" class="affpopup" co-rid="_co_idm140460568251200" co-class="co-affbox">Hao Zhang</a>,<sup>1,</sup><sup>#</sup> <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Song%20J%5BAuthor%5D" class="affpopup" co-rid="_co_idm140460568248480" co-class="co-affbox">Jingwei Song</a>,<sup>1</sup> <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Zhang%20Y%5BAuthor%5D" class="affpopup" co-rid="_co_idm140460568246496" co-class="co-affbox">Yenan Zhang</a>,<sup>1</sup> <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Xing%20J%5BAuthor%5D" class="affpopup" co-rid="_co_idm140460566349424" co-class="co-affbox">Jicheng Xing</a>,<sup>3</sup> <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Yang%20Z%5BAuthor%5D" class="affpopup" co-rid="_co_idm140460566347440" co-class="co-affbox">Zhihui Yang</a>,<sup>3</sup> <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Wei%20C%5BAuthor%5D" class="affpopup" co-rid="_co_idm140460566345456" co-class="co-affbox">Changyong Wei</a>,<sup>4</sup> <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Xu%20T%5BAuthor%5D" class="affpopup" co-rid="_co_idm140460566343472" co-class="co-affbox">Tuoye Xu</a>,<sup>5</sup> <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Yu%20Z%5BAuthor%5D" class="affpopup" co-rid="_co_idm140460573683776" co-class="co-affbox">Zhennan Yu</a>,<sup>5</sup> <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Xu%20Z%5BAuthor%5D" class="affpopup" co-rid="_co_idm140460573681792" co-class="co-affbox">Zhipeng Xu</a>,<sup>1,</sup><sup>2</sup> <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Hou%20M%5BAuthor%5D" class="affpopup" co-rid="_co_idm140460573679072" co-class="co-affbox">Min Hou</a>,<sup>1</sup> <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Ji%20M%5BAuthor%5D" class="affpopup" co-rid="_co_idm140460563012416" co-class="co-affbox">Minjun Ji</a>,<sup>1,</sup><sup>2,</sup><sup>&#x02709;</sup> and  <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Zhang%20Y%5BAuthor%5D" class="affpopup" co-rid="_co_idm140460563008960" co-class="co-affbox">Yansong Zhang</a><sup>5</sup></div><div style="display:none" class="contrib-group aff-tip"><div id="_co_idm140460571009680"><h3 class="no_margin">Hongzhi Sun</h3><p><sup>1</sup>Department of Pathogen Biology, Nanjing Medical University, Nanjing, Jiangsu, 211166, China.</p><div>Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Sun%20H%5BAuthor%5D">Hongzhi Sun</a></div></div><div id="_co_idm140460571007568"><h3 class="no_margin">Bingya Yang</h3><p><sup>1</sup>Department of Pathogen Biology, Nanjing Medical University, Nanjing, Jiangsu, 211166, China.</p><p><sup>2</sup>Jiangsu Province Key Laboratory of Modern Pathogen Biology, Nanjing, Jiangsu, 211166, China.</p><div>Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Yang%20B%5BAuthor%5D">Bingya Yang</a></div></div><div id="_co_idm140460568251200"><h3 class="no_margin">Hao Zhang</h3><p><sup>1</sup>Department of Pathogen Biology, Nanjing Medical University, Nanjing, Jiangsu, 211166, China.</p><div>Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Zhang%20H%5BAuthor%5D">Hao Zhang</a></div></div><div id="_co_idm140460568248480"><h3 class="no_margin">Jingwei Song</h3><p><sup>1</sup>Department of Pathogen Biology, Nanjing Medical University, Nanjing, Jiangsu, 211166, China.</p><div>Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Song%20J%5BAuthor%5D">Jingwei Song</a></div></div><div id="_co_idm140460568246496"><h3 class="no_margin">Yenan Zhang</h3><p><sup>1</sup>Department of Pathogen Biology, Nanjing Medical University, Nanjing, Jiangsu, 211166, China.</p><div>Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Zhang%20Y%5BAuthor%5D">Yenan Zhang</a></div></div><div id="_co_idm140460566349424"><h3 class="no_margin">Jicheng Xing</h3><p><sup>3</sup>Department of Clinical laboratory, Bayi Hospital Affiliated to Nanjing University Of Chinese Medicine, Nanjing, Jiangsu, 210002, China.</p><div>Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Xing%20J%5BAuthor%5D">Jicheng Xing</a></div></div><div id="_co_idm140460566347440"><h3 class="no_margin">Zhihui Yang</h3><p><sup>3</sup>Department of Clinical laboratory, Bayi Hospital Affiliated to Nanjing University Of Chinese Medicine, Nanjing, Jiangsu, 210002, China.</p><div>Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Yang%20Z%5BAuthor%5D">Zhihui Yang</a></div></div><div id="_co_idm140460566345456"><h3 class="no_margin">Changyong Wei</h3><p><sup>4</sup>Department of Hematology and Medical Oncology, School of Medicine, Emory University, Atlanta, GA 30322, USA.</p><div>Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Wei%20C%5BAuthor%5D">Changyong Wei</a></div></div><div id="_co_idm140460566343472"><h3 class="no_margin">Tuoye Xu</h3><p><sup>5</sup>Department of Neurosurgery, Brain Hospital, affiliated to Nanjing medical University, Nanjing, 210029, China.</p><div>Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Xu%20T%5BAuthor%5D">Tuoye Xu</a></div></div><div id="_co_idm140460573683776"><h3 class="no_margin">Zhennan Yu</h3><p><sup>5</sup>Department of Neurosurgery, Brain Hospital, affiliated to Nanjing medical University, Nanjing, 210029, China.</p><div>Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Yu%20Z%5BAuthor%5D">Zhennan Yu</a></div></div><div id="_co_idm140460573681792"><h3 class="no_margin">Zhipeng Xu</h3><p><sup>1</sup>Department of Pathogen Biology, Nanjing Medical University, Nanjing, Jiangsu, 211166, China.</p><p><sup>2</sup>Jiangsu Province Key Laboratory of Modern Pathogen Biology, Nanjing, Jiangsu, 211166, China.</p><div>Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Xu%20Z%5BAuthor%5D">Zhipeng Xu</a></div></div><div id="_co_idm140460573679072"><h3 class="no_margin">Min Hou</h3><p><sup>1</sup>Department of Pathogen Biology, Nanjing Medical University, Nanjing, Jiangsu, 211166, China.</p><div>Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Hou%20M%5BAuthor%5D">Min Hou</a></div></div><div id="_co_idm140460563012416"><h3 class="no_margin">Minjun Ji</h3><p><sup>1</sup>Department of Pathogen Biology, Nanjing Medical University, Nanjing, Jiangsu, 211166, China.</p><p><sup>2</sup>Jiangsu Province Key Laboratory of Modern Pathogen Biology, Nanjing, Jiangsu, 211166, China.</p><div>Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Ji%20M%5BAuthor%5D">Minjun Ji</a></div></div><div id="_co_idm140460563008960"><h3 class="no_margin">Yansong Zhang</h3><p><sup>5</sup>Department of Neurosurgery, Brain Hospital, affiliated to Nanjing medical University, Nanjing, 210029, China.</p><div>Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Zhang%20Y%5BAuthor%5D">Yansong Zhang</a></div></div></div></div><div class="half_rhythm"><div class="togglers fm-copyright-license"><a href="#" class="pmctoggle" rid="idm140460567415792_ai">Author information</a> <a href="#" class="pmctoggle" rid="idm140460567415792_an">Article notes</a> <a href="#" class="pmctoggle" rid="idm140460567415792_cpl">Copyright and License information</a> <a href="/pmc/about/disclaimer/" style="margin-left: 1em">PMC Disclaimer</a></div><div class="fm-authors-info hide half_rhythm" id="idm140460567415792_ai" style="display:none"><div class="fm-affl" id="A1"><sup>1</sup>Department of Pathogen Biology, Nanjing Medical University, Nanjing, Jiangsu, 211166, China.</div><div class="fm-affl" id="A2"><sup>2</sup>Jiangsu Province Key Laboratory of Modern Pathogen Biology, Nanjing, Jiangsu, 211166, China.</div><div class="fm-affl" id="A3"><sup>3</sup>Department of Clinical laboratory, Bayi Hospital Affiliated to Nanjing University Of Chinese Medicine, Nanjing, Jiangsu, 210002, China.</div><div class="fm-affl" id="A4"><sup>4</sup>Department of Hematology and Medical Oncology, School of Medicine, Emory University, Atlanta, GA 30322, USA.</div><div class="fm-affl" id="A5"><sup>5</sup>Department of Neurosurgery, Brain Hospital, affiliated to Nanjing medical University, Nanjing, 210029, China.</div><div id="FNA_envelop">&#x02709; Corresponding author: Minjun Ji, email: <a href="mailto:dev@null" data-email="nc.ude.umjn@nujnimij" class="oemail">nc.ude.umjn@nujnimij</a></div><div id="FNA_number"><sup>#</sup> Contributed equally.</div><div id="fn-a.k.b.k.c">Competing Interests: The authors have declared that no competing interest exists.</div></div><div class="fm-article-notes hide half_rhythm" id="idm140460567415792_an" style="display:none"><div class="fm-pubdate half_rhythm">Received 2018 Jan 27; Accepted 2018 Nov 9.</div></div><div class="permissions half_rhythm hide" id="idm140460567415792_cpl" style="display:none"><div class="fm-copyright half_rhythm"><a href="/pmc/about/copyright/">Copyright</a> &#x000a9; Ivyspring International Publisher</div><div class="license half_rhythm">This is an open access article distributed under the terms of the Creative Commons Attribution (CC BY-NC) license (<a href="https://creativecommons.org/licenses/by-nc/4.0/" data-ga-action="click_feat_suppl" ref="reftype=extlink&amp;article-id=6367584&amp;issue-id=329202&amp;journal-id=294&amp;FROM=Article%7CFront%20Matter&amp;TO=External%7CLink%7CURI" target="_blank">https://creativecommons.org/licenses/by-nc/4.0/</a>). See <a href="http://ivyspring.com/terms" data-ga-action="click_feat_suppl" ref="reftype=extlink&amp;article-id=6367584&amp;issue-id=329202&amp;journal-id=294&amp;FROM=Article%7CFront%20Matter&amp;TO=External%7CLink%7CURI" target="_blank">http://ivyspring.com/terms</a> for full terms and conditions.</div></div></div><div id="pmclinksbox" class="links-box whole_rhythm hidden" role="complementary" aria-label="Related or updated information about this article."></div></div><div class="sec"></div><div id="ass-data" class="tsec fm-sec whole_rhythm" data-section="Featured_PMC_Datacitation"><h2 class="nomenu">Associated Data</h2><dl data-count="2" class="box-data-suppmats whole_rhythm no_bottom_margin"><dt><a href="#" rid="data-suppmats" data-ga-action="click_feat_toggler" data-ga-label="Supplementary Materials" class="pmctoggle">Supplementary Materials</a></dt><dd id="data-suppmats" style="display: none;"><div class="half_rhythm"><div class="caption half_rhythm no_bottom_margin">Supplementary figures.</div><div><a href="/pmc/articles/PMC6367584/bin/ijbsv15p0533s1.pdf" data-ga-action="click_feat_suppl">ijbsv15p0533s1.pdf</a><span style="color:gray"> (813K)</span></div><div class="small guid">GUID: 5BD3E200-9DFB-4046-AE58-F0222FF3DDBC</div></div><div class="half_rhythm"><div class="caption half_rhythm no_bottom_margin">Supplementary table.</div><div><a href="/pmc/articles/PMC6367584/bin/ijbsv15p0533s2.xlsx" data-ga-action="click_feat_suppl">ijbsv15p0533s2.xlsx</a><span style="color:gray"> (807K)</span></div><div class="small guid">GUID: A15CA8B7-534F-40FE-9C6A-B2EDD5AF6270</div></div></dd></dl></div><div id="abstract-a.k.b.t" lang="en" class="tsec sec"><h2 class="head no_bottom_margin" id="abstract-a.k.b.ttitle">Abstract</h2><!--article-meta--><div><p class="p p-first-last">Glioma is one of the most common brain tumors, suggesting the importance of investigating the molecular mechanism of gliomas. We studied the roles of Ribonucleotide Reductase Regulatory Subunit M2 (RRM2) in glioma. Expressions of RRM2 are higher in glioma tissues evidenced by TCGA data, western blot and immunohistochemistry. RRM2 is negatively correlated with glioma patient's survival. RNA-seq showed that genes involved in apoptosis, proliferation, cell adhesion and negative regulation of signaling were up-regulated upon RNAi-mediated knock-down of RRM2. Cell phenotypes specific for stably knocking down RRM2 were determined using stable transfection <em>in vitro</em>. In an <em>in vivo</em> model, knock-down of RRM2 inhibited tumor growth and caused suppression of AKT and ERK1/2 signalings. Interfering RRM2 also down-regulated the expression of cyclin A, cyclin B1, cyclin D1, Vimentin, and N-cadherin, and elevated E-cadherin expression. Moreover, overexpression of RRM2 failed to increase the expression of cyclin B1, cyclin D1, and N-cadherin when phosphorylation of AKT and ERK1/2 was suppressed by LY294002 or PD98059. These findings indicated that RRM2 is a positive regulator of glioma progression which contributes to the migration and proliferation of glioma cells through ERK1/2 and AKT signalings and might be a novel prognostic indicator for glioma patients.</p></div><div class="sec"><strong class="kwd-title">Keywords: </strong><span class="kwd-text">RRM2, Knock-down, G2/M phase arrest, ERK1/2, AKT</span></div></div><div id="sec-a.l.a" class="tsec sec"><h2 class="head no_bottom_margin" id="sec-a.l.atitle">Introduction</h2><p class="p p-first">Glioma is the most common type of primary brain tumor in China, the United States, and European countries <sup><a href="#B1" rid="B1" class=" bibr popnode">1</a></sup><sup>, </sup><sup><a href="#B2" rid="B2" class=" bibr popnode">2</a></sup>, accounting for about 80% of tumors starting in the brain per year <sup><a href="#B3" rid="B3" class=" bibr popnode">3</a></sup>. The treatment of gliomas includes surgical resection coupled with radiotherapy and chemotherapy <sup><a href="#B4" rid="B4" class=" bibr popnode">4</a></sup>. Unfortunately, gliomas often relapse in almost all patients, and the prognosis of glioblastoma (GBM, WHO grade IV glioma) patients remains dismal <sup><a href="#B5" rid="B5" class=" bibr popnode">5</a></sup><sup>, </sup><sup><a href="#B6" rid="B6" class=" bibr popnode">6</a></sup>. It is characterized as invasive, whose underlying molecular mechanisms need to be explored in detail <sup><a href="#B7" rid="B7" class=" bibr popnode">7</a></sup><sup>, </sup><sup><a href="#B8" rid="B8" class=" bibr popnode">8</a></sup>. Therefore, investigation of the mechanisms involved in tumor invasion, proliferation, and apoptosis may offer profound insights into the treatment of gliomas.</p><p>Deregulated cell cycle has been determined in many types of cancers, including GBM. Ribonucleotide reductase is an enzyme involved in the cell cycle. It is composed of two subunits, the regulatory subunit RRM1 and catalytic subunit RRM2 <sup><a href="#B9" rid="B9" class=" bibr popnode">9</a></sup><sup>, </sup><sup><a href="#B10" rid="B10" class=" bibr popnode">10</a></sup>, which are essential for DNA replication and repair <sup><a href="#B11" rid="B11" class=" bibr popnode">11</a></sup>. An abnormally upregulated RRM2 expression has been demonstrated to promote fast cell division by increasing dNTP accumulation and is therefore involved in many kinds of cancers including colorectal cancer, non-small cell lung cancer (NSCLC), breast cancer, bladder cancer, ovarian cancer, pancreatic cancer, head and neck cancer<sup><a href="#B12" rid="B12" class=" bibr popnode">12</a></sup><sup>-</sup><sup><a href="#B16" rid="B16" class=" bibr popnode">16</a></sup>. RRM2 is also related to poor prognosis in cancers. For example, cervical cancer patients with positive RRM2 expression exhibited a higher recurrent rate and lower survival than those with negative RRM2 expression <sup><a href="#B17" rid="B17" class=" bibr popnode">17</a></sup>. RRM2 also can be considered as a prognostic marker for NSCLC and pancreatic cancer <sup><a href="#B18" rid="B18" class=" bibr popnode">18</a></sup><sup>, </sup><sup><a href="#B19" rid="B19" class=" bibr popnode">19</a></sup>. Besides, it has been reported that RRM2 dysregulation is associated with chemoresistance during cancer treatment. Downregulation of RRM2 could overturn the AKT-mediated tamoxifen resistance and improve therapeutic efficacy in breast cancer <sup><a href="#B20" rid="B20" class=" bibr popnode">20</a></sup>, and a previous study showed that patients with lower RRM2 expression could overcome the gemcitabine resistance in pancreatic cancer <sup><a href="#B21" rid="B21" class=" bibr popnode">21</a></sup>.</p><p class="p p-last">The primary objective of the presented study was to characterize the function of RRM2 on glioma cells. Here, the transcriptome of RRM2 shRNA-transfected U87 glioma cells was analyzed by RNA-Seq to explore the effects of RRM2 knock-down. The biological function and molecular mechanism of RRM2 on migration, proliferation and apoptosis were investigated both<em> in vivo</em> and <em>in vitro</em>. Finally, on the grounds that PI3K/AKT and MAPK signalings pathways play an important role in the development of cancers, including gliomas <sup><a href="#B22" rid="B22" class=" bibr popnode">22</a></sup>, the relationship between RRM2, PI3K/AKT and MAPK has been explored for further research. Therefore, this study will contribute to a deeper understanding of RRM2 and develop efficient strategies against RRM2 overexpressing gliomas.</p></div><div id="sec-a.l.b" class="tsec sec"><h2 class="head no_bottom_margin" id="sec-a.l.btitle">Materials and Methods</h2><div id="sec-a.l.b.b" class="sec sec-first"><h3 id="sec-a.l.b.btitle">Data acquisition from TCGA (the cancer genome atlas) and survival analysis</h3><p class="p p-first-last">Gene expression quantification data (HTSeq - FPKM) in TCGA-GBM project was downloaded from the TCGA using the TCGAbiolinks R package <sup><a href="#B23" rid="B23" class=" bibr popnode">23</a></sup>. A total of 156 tumor samples and 5 normal paired normal sample were included in the RRM2 expression comparison. To evaluate the relationship between RRM2 expression and survival of GBM patients, Kaplan-Meier survival curve (overall) was analyzed using the SynTarget/BioProfiling database <sup><a href="#B24" rid="B24" class=" bibr popnode">24</a></sup> for the TCGA_GBM dataset (121 patient samples).</p></div><div id="sec-a.l.b.c" class="sec"><h3 id="sec-a.l.b.ctitle">Cell culture</h3><p class="p p-first-last">Human glioma cell lines, U87 and LN-229, were purchased from ATCC (American Type Culture Collection) (Manassas, VA, USA). The cells were cultured in DMEM media supplemented with 0.5% Penicillin-Streptomycin Solution (Gibco, Waltham, MA, USA) and 10% fetal bovine serum (FBS) (Gibco, Waltham, MA, USA), maintained at 37 &#x000b0;C in humidified air with 5% CO2.</p></div><div id="sec-a.l.b.d" class="sec"><h3 id="sec-a.l.b.dtitle">Histopathology and Immunohistochemistry</h3><p class="p p-first-last">The adjacent normal and tumor samples of human patients were collected from Ba Yi Hospital, Nanjing, China. The study was performed with the approval of the Ethics Committee of Ba Yi Hospital. All tumor tissues were fixed in 10 % neutral formalin, trimmed appropriately in chemical hood after fixation (at least 24 hours). Then the samples were dehydrated and permeated with paraffin wax. Tissue samples were processed in melted paraffin in cassettes and frozen at -20&#x000b0;C until paraffin solidify completely. 4&#x003bc;m sections were prepared using microtome. The standard protocol used for the immunohistochemistry was provided in our previous study <sup><a href="#B25" rid="B25" class=" bibr popnode">25</a></sup>.The polyclonal anti-RRM2 and anti-Ki-67 (diluted at 1:100, Santa Cruz, CA) was incubated as the primary antibody overnight at 4&#x000b0;C. The slide without primary antibody incubation was used as negative control. After washing with phosphate-buffered saline (PBS), these tissues were incubated with the secondary antibodies, which were horseradish peroxidase-conjugated anti-rabbit or anti-mouse IgG (Envision kit, Dako, Denmark) following the manufacturer's instructions. At last, these sections were stained with hematoxylin. The TMA immunostaining images were captured using microscope from Carl Zeiss (Axio Observer A1, Jena, Germany) and analyzed by Image-Pro Plus 6.0 software.</p></div><div id="sec-a.l.b.e" class="sec"><h3 id="sec-a.l.b.etitle">Quantification of Ki67 and RRM2 expression</h3><p class="p p-first-last">A total of 54 patients with brain tumors diagnosed at the department of Oncology-Pathology, Ba Yi Hospital, Nanjing, China. All histologic specimens were routinely stained for RRM2 and Ki-67 by immunohistochemistry. Tumors with histopathologic grading I and graded II were considered as low-grade tumors, whereas those graded III to IV were high-grade tumors. Permission to analyze the samples and correlate the results to patient data was obtained by the Ethics Committee of Ba Yi Hospital. Only distinct nuclear staining was accepted as a positive reaction for both markers. All cells with simultaneous nuclear staining and cytoplasmic RRM2 staining were regarded as positive for RRM2. The hot spot was arbitrarily defined as an area with 25 mm<sup>2</sup> around the point with the highest concentration of cells immunoreactive for RRM2 or Ki-67 antigen in the tumor. In each area, the positive cells among 200 to 400 cells were counted in a X200 magnification manually. The RRM2and Ki-67 score were calculated as the percentage of positive cells. Data were analyzed using SPSS version 17.0 (SPSS, Chicago, Illinois). The correlation between RRM2 and Ki-67 was evaluated by Pearson correlation coefficient.</p></div><div id="sec-a.l.b.f" class="sec"><h3 id="sec-a.l.b.ftitle">RRM2 knock-down in glioma cells</h3><p class="p p-first-last">Plasmids of shRNAs targeting RRM2 and scrambled shRNA were purchased from GenePharma (Shanghai, China). The shRNA of RRM2 or scrambled was transfected into U87 or LN-229 cells using lipofectamine 2000 (Invitrogen, California, USA), followed by 40 days of selection with 600 &#x003bc;g/mL of puromycin. The RRM2 shRNAs (shRRM2#1 and shRRM2#2) target the sequences: GGU CCU ACA UUA GUG CCU UTT and GCU GUA CUA UCU GCG AAA UTT, respectively. RRM2 knock-down in these cells was confirmed by Western blot.</p></div><div id="sec-a.l.b.g" class="sec"><h3 id="sec-a.l.b.gtitle">RNA library construction and sequencing</h3><p class="p p-first-last">A total amount of 1&#x003bc;g qualified RNA per sample was used as input material for the library preparation. The sequencing libraries were generated using the VAHTS mRNA-seq v2 Library Prep Kit for Illumina&#x000ae; (Vazyme, NR601) following manufacturer's recommendations. Firstly, mRNA was purified from total RNA using poly-T oligo-attached magnetic beads. Fragmentation was performed using divalent cations under elevated temperature in Vazyme Frag/Prime Buffer. The cleaved RNA fragments were copied into first strand cDNA using reverse transcriptase and random primers. Second strand cDNA synthesis was subsequently performed using buffer, dNTPs, DNA polymerase I and RNase H. Then, the cDNA fragments were end repaired with the addition of a single 'A' base at the 3'-end of each strand, ligated with the special sequencing adapters (Vazyme, N803) subsequently. The products were purified and size selected with VAHTSTM DNA Clean Beads (Vazyme, N411) in order to get appropriate size for sequencing. Following amplification, cDNA was purified and subjected to library construction for the paired-end 150 bp (PE150) sequencing on Illumina HiSeq X Ten platform.</p></div><div id="sec-a.l.b.h" class="sec"><h3 id="sec-a.l.b.htitle">Read alignment and differential expression analysis</h3><p class="p p-first-last">Raw reads were trimmed to remove low-quality bases and adaptor sequences using Fastp (v0.18.0) <sup><a href="#B26" rid="B26" class=" bibr popnode">26</a></sup> with default parameters. Ribosomal RNA were further removed by SortmeRNA (v2.1b) <sup><a href="#B27" rid="B27" class=" bibr popnode">27</a></sup>. After cleaning and quality checks, we obtained 45.7 and 56.2 million reads from control and RRM2 knock-down sample. Filtered reads were then aligned against human genome reference (hg38) by application of Hisat2 (v2.05) <sup><a href="#B28" rid="B28" class=" bibr popnode">28</a></sup>. Differentially expressed genes were deemed significant using GFOLD algorithm (v1.1.4) <sup><a href="#B29" rid="B29" class=" bibr popnode">29</a></sup> which was more biologically meaningful for single replicate experiments. Genes with an absolute GFOLD &#x02260;0 and fold change&#x0003e;1.3 were considered differentially expressed. Gene Set Enrichment Analysis (GSEA) and Gene Ontology (GO) over-representation test were performed using an R package clusterProfiler <sup><a href="#B30" rid="B30" class=" bibr popnode">30</a></sup> (v3.9.2) to find enriched GO terms (p-value cutoff 0.05) in up- or down-regulated genes. GO terms were simplified using the simplify function of clusterProfiler. The data were plotted using the ggplot2 R package <sup><a href="#B31" rid="B31" class=" bibr popnode">31</a></sup>. All sequencing data were deposited in the sequence read archive (SRA) database and the BioProject ID is PRJNA505067.</p></div><div id="sec-a.l.b.i" class="sec"><h3 id="sec-a.l.b.ititle">Cell growth and colony formation assay</h3><p class="p p-first-last">The growth of glioma cells was determined by the CCK-8 Kit (YEASEN, Shanghai, China) following the manufacturer's protocol. During the assay to examine colony formation, about 2,000 transfected cells per dish were plated in 6-well plate. After 14 days, the cells were fixed with 4% paraformaldehyde for 30 min and stained with 0.5% crystal violet for 30 minutes. Then gently wash it three times with PBS, the number of cell colonies was calculated.</p></div><div id="sec-a.l.b.j" class="sec"><h3 id="sec-a.l.b.jtitle">Cell cycle analyzed by flow cytometry</h3><p class="p p-first-last">60% of the digested Glioma cell lines which stably knocking out the gene of interest were added into the 6-well plate and incubating the cells for 12 hours overnight. Then Cells were collected by trypsinization after the PBS washing, fixed with 70% methanol for 5 hours at 4&#x000b0;C, and incubated with ribonuclease A for half an hour at 37&#x000b0;C. Their nuclei were then labeled in the dark with 100 ng/mL PI (propidium iodide). In the end, the cells were analyzed by a flow cytometer (Becton Dickinson, USA).</p></div><div id="sec-a.l.b.k" class="sec"><h3 id="sec-a.l.b.ktitle">Cell apoptosis analyzed by flow cytometry</h3><p class="p p-first-last">Detection of apoptotic cells was carried out using Annexin V-FITC/propidium iodide (PI)-labeled apoptosis detection kit (Beyotime, Shanghai, China). Briefly, glioma cells which stably transfected with shRRM2 or shNC were plated in 10 cm dishes and cultured in DMEM with 10% FBS. When the cells are over 90% in the dishes, the transfected cells were harvested and centrifuged for 5 min at 4&#x000b0;C, 250xg. Then, these cells were resuspended in cold binding buffer (10 mM HEPES buffer pH 7.4, 5 mM KCl, 150 mM NaCl, 1.8 mM CaCl<sub>2</sub>, and 1 mM MgCl<sub>2</sub>). These cells were firstly stained with FITC-labeled 25 ng/mL Annexin V in the dark for 30 min and then stained with 50 ng/mL propidium iodide for 5 min. These samples were run with a Becton Dickinson flow cytometer and the data were analyzed with Cell Quest software. In this study, the apoptotic cells were the population of Annexin V-positive and PI-negative cells. Annexin V and PI double positive cells were scored as necrotic or late apoptotic.</p></div><div id="sec-a.l.b.l" class="sec"><h3 id="sec-a.l.b.ltitle">Wound-healing assay of glioma cells</h3><p class="p p-first-last">The U87 or LN-229 cells which have been stably knocked down the RRM2 gene were planted in 6-well plates and the cells would grow to confluence after about 16 hours. Then the cells were cultured with serum-free DMEM for 12 h and then the monolayer was scratched by a 10-&#x003bc;L pipette tip. These cultured samples were photographed every 12 hours by a microscope from Carl Zeiss (Axio Observer A1, Jena, Germany). The number of the cells migrated to the wound was calculated.</p></div><div id="sec-a.l.b.m" class="sec"><h3 id="sec-a.l.b.mtitle">Transwell migration assay</h3><p class="p p-first-last">The glioma cells (U87 and LN-229) stably expressing shRRM2 or shNC were cultured in DMEM with 0.1% FBS for 12 hours. Then, 1 &#x000d7; 10<sup>5</sup> cells were placed on the upper layer of a cell culture insert with permeable membrane (8 &#x003bc;m pore size, Corning, Shanghai, China), and DMEM with 10% FBS was applied to the lower layer. After incubation at 37 &#x000b0;C for 14 hours, migrated cells in the lower layer were fixed with paraformaldehyde and stained with crystal violet to visualize nuclei, and non-migrated cells in the upper layer were removed. The number of migrating cells in six fields was counted under &#x000d7;200 magnification. The experiments were repeated three times.</p></div><div id="sec-a.l.b.n" class="sec"><h3 id="sec-a.l.b.ntitle"><em>In vivo</em> tumor growth</h3><p class="p p-first-last">All animal procedures were approved by the Institutional Animal Care and Use Committee of Nanjing Medical University (SYXK 2015-0015). All animals received human care and all animal experiments were conducted in accordance with the relevant guidelines and regulations. The animals were purchased from Beijing Vital River Laboratory Animal Technology Co., Ltd. (Beijing, China). About 6 &#x000d7; 10<sup>6</sup> U87 cells (200 &#x003bc;L) stably transfected with shRRM2 or shNC were injected subcutaneously into the right flank of each Nude mouse (4 weeks old male nude mice, n=4). The mice were housed in cages with sawdust bedding in a specific pathogen-free room at a temperature of 25-26&#x000b0;C and a relative humidity of ~50%, light 12 h/day. Tumor volumes and body weight were measured by vernier calipers every five days. Tumor volume was assessed conforming to the formula: volume = (longest diameter x shortest diameter<sup>2</sup>)/2<sup><a href="#B32" rid="B32" class=" bibr popnode">32</a></sup>. Mice were sacrificed at the fortieth day after the beginning intratumoral injection of glioma cells. The tumors were harvested and stored at -80&#x000b0;C for further studies.</p></div><div id="sec-a.l.b.o" class="sec"><h3 id="sec-a.l.b.otitle">Western blot</h3><p class="p p-first-last">The cells or tissues from <em>in vitro</em> or <em>in vivo</em> experiments were lysed in RIPA Buffer (1 mM EDTA pH 8.0, 50 mM Tris-HCl pH 8.0, 2% SDS, 5 mM DTT), and their protein concentration was determined by the BCA assay (Beyotime, Shanghai, China). The total protein (100 &#x003bc;g) was separated by 10%-15% SDS-PAGE gel and transferred to PVDF (polyvinylidene fluoride) membranes (Invitrogen, California, USA), and blocked with 5% skimmed milk powder in PBST (Phosphate Buffered Saline with Tween) or 5% w/v BSA, 1&#x000d7;TBS, 0.1% Tween at 4&#x000b0;C with gentle shaking about 12 hours. The membranes were immunoblotted with the primary antibodies for 4 hours at room temperature or overnight at 4&#x000b0;C and then incubated with the secondary antibodies for 2 hours. The corresponding semi-quantitative analysis was based on optical density with Image J software. In western blot analysis, cyclin B1, cyclin D1, BCL-2 (Boster Biological Technology), cyclin A, BAX, PARP, caspase-3, Vimentin (Proteintech), GAPDH (Bioworld), RRM2, E-cadherin, N-cadherin, phospho-AKT (T308), and phospho-ERK1/2 (T202/Y204) (Cell Signaling) were used for immunoblotting with secondary antibodies conjugated with horseradish peroxidase (Bioworld) and visualized with Bio-Rad ChemiDoc&#x02122; Imagers. All other chemical reagents were bought from Sigma (Shanghai, China).</p></div><div id="sec-a.l.b.p" class="sec sec-last"><h3 id="sec-a.l.b.ptitle">Statistical analysis</h3><p class="p p-first-last">All the results are shown as mean &#x000b1; SD. Statistically significant differences between two groups were assessed by &#x003c7;2 analysis and student's t-test using GraphPad Prism 7.0. P-value &#x0003c; 0.05 was considered to be statistically significant.</p></div></div><div id="sec-a.l.c" class="tsec sec"><h2 class="head no_bottom_margin" id="sec-a.l.ctitle">Results</h2><div id="Section1" class="sec sec-first"><h3 id="Section1title">1. RRM2 expression is enhanced in human glioma tissues</h3><p class="p p-first">To evaluate the significance of RRM2 in glioma patients, we compared its expression between primary tumor and normal tissue group in TCGA-GBM project. RRM2 were statistically increased in tumor group as shown in Fig. <a href="/pmc/articles/PMC6367584/figure/F1/" target="figure" class="fig-table-link figpopup" rid-figpopup="F1" rid-ob="ob-F1" co-legend-rid="lgnd_F1"><span style="position: relative;text-decoration:none;">&#x200B;<span class="figpopup-sensitive-area" style="left: -2em;">Fig.1A.</span></span><span>1</span></a>A. It has been demonstrated that high RRM2 expression is an indicator of poor prognosis in many types of cancer <sup><a href="#B17" rid="B17" class=" bibr popnode">17</a></sup><sup>-</sup><sup><a href="#B19" rid="B19" class=" bibr popnode">19</a></sup><sup>, </sup><sup><a href="#B33" rid="B33" class=" bibr popnode">33</a></sup><sup>-</sup><sup><a href="#B35" rid="B35" class=" bibr popnode">35</a></sup>. Here, we analyzed the relationship between RRM2 expression and the survival of GBM patients. Survival data were retrieved from SynTarget/BioProfiling database (TCGA_GBM) <sup><a href="#B24" rid="B24" class=" bibr popnode">24</a></sup>. Patients with higher RRM2 expression rank than the average RRM2 expression rank across the TCGA_GBM dataset were classified as the high RRM2 group (52 cases), and the others were in the low RRM2 group (69 cases). The overall survival was compared between the two groups. The results showed that high RRM2 patients exhibited a significantly poorer survival outcome than the low RRM2 patients (Fig. <a href="/pmc/articles/PMC6367584/figure/F1/" target="figure" class="fig-table-link figpopup" rid-figpopup="F1" rid-ob="ob-F1" co-legend-rid="lgnd_F1"><span style="position: relative;text-decoration:none;">&#x200B;<span class="figpopup-sensitive-area" style="left: -2.5em;">(Fig.1B).</span></span><span>1</span></a>B). Thus, RRM2 might be considered as a prognostic marker for GBM.</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm" id="F1" co-legend-rid="lgnd_F1"><a href="/pmc/articles/PMC6367584/figure/F1/" target="figure" rid-figpopup="F1" rid-ob="ob-F1"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div class="figure" data-largeobj="" data-largeobj-link-rid="largeobj_idm140460567632112"><a class="inline_block ts_canvas" href="/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=6367584_ijbsv15p0533g001.jpg" target="tileshopwindow" rel="noopener"><div class="ts_bar small" title="Click on image to zoom"></div><img loading="lazy" alt="An external file that holds a picture, illustration, etc.&#10;Object name is ijbsv15p0533g001.jpg" title="Click on image to zoom" class="tileshop" src="/pmc/articles/PMC6367584/bin/ijbsv15p0533g001.jpg" /></a></div><div class="largeobj-link align_right" id="largeobj_idm140460567632112"><a target="object" rel="noopener" href="/pmc/articles/PMC6367584/figure/F1/?report=objectonly">Open in a separate window</a></div></a><div class="icnblk_cntnt" id="lgnd_F1"><div><a class="figpopup" href="/pmc/articles/PMC6367584/figure/F1/" target="figure" rid-figpopup="F1" rid-ob="ob-F1">Fig 1</a></div><!--caption a7--><div class="caption"><p>Expression of RRM2 in human gliomas and normal brain tissues. <strong>A</strong> Expression of RRM2 in human normal brain tissues and GBM tissues from TCGA-GBM project. <strong>B</strong> Survival curve of the effect of the RRM2 gene on the survival time of GBM patients.<strong> C</strong> Immunohistochemistry (original magnification, &#x000d7;200): Compared with adjacent normal human brain tissue and low-grade glioma, the expression of RRM2 and Ki-67 were significantly up-regulated in high-grade glioma. <strong>D</strong> The correlation between RRM2 and Ki-67 in human gliomas analyzed by the Pearson's correlation coefficient test.</p></div></div></div><p class="p p-last">We also detected the expression of RRM2 and Ki-67 protein in paraffin sections of glioma samples and adjacent normal samples of brain tissues. As shown in Fig. <a href="/pmc/articles/PMC6367584/figure/F1/" target="figure" class="fig-table-link figpopup" rid-figpopup="F1" rid-ob="ob-F1" co-legend-rid="lgnd_F1"><span style="position: relative;text-decoration:none;">&#x200B;<span class="figpopup-sensitive-area" style="left: -2em;">Fig.1C-D,</span></span><span>1</span></a>C-D, there was much more positive staining of RRM2 as well as Ki-67 staining in high-grade gliomas than in low-grade gliomas and adjacent normal brain tissues. It suggested that RRM2 expression was positively associated with Ki-67 expression and the grade of gliomas (Fig. <a href="/pmc/articles/PMC6367584/figure/F1/" target="figure" class="fig-table-link figpopup" rid-figpopup="F1" rid-ob="ob-F1" co-legend-rid="lgnd_F1"><span style="position: relative;text-decoration:none;">&#x200B;<span class="figpopup-sensitive-area" style="left: -2.5em;">(Fig.1D).</span></span><span>1</span></a>D). Additionally, the correlation with high expression of RRM2 and high grade of gliomas was not affected by patients' age, gender, and tumor size (Table <a href="/pmc/articles/PMC6367584/table/T1/" target="table" class="fig-table-link figpopup" rid-figpopup="T1" rid-ob="ob-T1" co-legend-rid=""><span style="position: relative;text-decoration:none;">&#x200B;<span class="figpopup-sensitive-area" style="left: -3em;">(Table1</span></span><span>1</span></a>).</p><!--table ft1--><!--table-wrap mode="anchored" t5--><div class="table-wrap anchored whole_rhythm" id="T1"><h3>Table 1</h3><!--caption a7--><div class="caption"><p>RRM2 expression and clinical characteristics of the 54 glioma patients.</p></div><div class="xtable"><table frame="hsides" rules="groups" class="rendered small default_table"><thead valign="top"><tr><th rowspan="1" colspan="1">Clinicopathologic feature</th><th rowspan="1" colspan="1">n (%)</th><th colspan="3" rowspan="1">RRM2</th><th rowspan="1" colspan="1">P-Value</th></tr></thead><tbody valign="top"><tr><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"><strong>Low</strong></td><td rowspan="1" colspan="1"><strong>High</strong></td><td rowspan="1" colspan="1"><strong>mean &#x000b1; SEM</strong></td><td rowspan="1" colspan="1"></td></tr><tr><td rowspan="1" colspan="1"><strong>Age</strong></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1">P=0.266</td></tr><tr><td rowspan="1" colspan="1">&#x02264;40</td><td rowspan="1" colspan="1">22 (40.74%)</td><td rowspan="1" colspan="1">9</td><td rowspan="1" colspan="1">13</td><td rowspan="1" colspan="1">2.54&#x000b1;0.21</td><td rowspan="1" colspan="1"></td></tr><tr><td rowspan="1" colspan="1">&#x02265;40</td><td rowspan="1" colspan="1">32 (59.26%)</td><td rowspan="1" colspan="1">14</td><td rowspan="1" colspan="1">18</td><td rowspan="1" colspan="1">2.60&#x000b1;0.18</td><td rowspan="1" colspan="1"></td></tr><tr><td rowspan="1" colspan="1"><strong>Gender</strong></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1">P=0.2027</td></tr><tr><td rowspan="1" colspan="1">Female</td><td rowspan="1" colspan="1">16 (29.62%)</td><td rowspan="1" colspan="1">7</td><td rowspan="1" colspan="1">9</td><td rowspan="1" colspan="1">1.81&#x000b1;0.17</td><td rowspan="1" colspan="1"></td></tr><tr><td rowspan="1" colspan="1">Male</td><td rowspan="1" colspan="1">38 (70.37%)</td><td rowspan="1" colspan="1">15</td><td rowspan="1" colspan="1">23</td><td rowspan="1" colspan="1">1.87&#x000b1;0.15</td><td rowspan="1" colspan="1"></td></tr><tr><td rowspan="1" colspan="1"><strong>Surgery</strong></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1">P=0.3836</td></tr><tr><td rowspan="1" colspan="1">Biopsy</td><td rowspan="1" colspan="1">8 (14.81%)</td><td rowspan="1" colspan="1">3</td><td rowspan="1" colspan="1">5</td><td rowspan="1" colspan="1">2.31&#x000b1;0.24</td><td rowspan="1" colspan="1"></td></tr><tr><td rowspan="1" colspan="1">Partial resection</td><td rowspan="1" colspan="1">17 (31.48%)</td><td rowspan="1" colspan="1">5</td><td rowspan="1" colspan="1">12</td><td rowspan="1" colspan="1">2.45&#x000b1;0.22</td><td rowspan="1" colspan="1"></td></tr><tr><td rowspan="1" colspan="1">Gross total resection</td><td rowspan="1" colspan="1">29 (53.71%)</td><td rowspan="1" colspan="1">10</td><td rowspan="1" colspan="1">19</td><td rowspan="1" colspan="1">2.37&#x000b1;0.27</td><td rowspan="1" colspan="1"></td></tr><tr><td rowspan="1" colspan="1"><strong>WHO Grade (%)</strong></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1">P&#x0003c;0.0001</td></tr><tr><td rowspan="1" colspan="1">&#x00406;&#x00406;</td><td rowspan="1" colspan="1">16 (29.62%)</td><td rowspan="1" colspan="1">6</td><td rowspan="1" colspan="1">10</td><td rowspan="1" colspan="1">1.71&#x000b1;0.23</td><td rowspan="1" colspan="1"></td></tr><tr><td rowspan="1" colspan="1">&#x00406;&#x00406;&#x00406;</td><td rowspan="1" colspan="1">18 (33.33%)</td><td rowspan="1" colspan="1">4</td><td rowspan="1" colspan="1">14</td><td rowspan="1" colspan="1">2.29&#x000b1;0.21</td><td rowspan="1" colspan="1"></td></tr><tr><td rowspan="1" colspan="1">IV</td><td rowspan="1" colspan="1">20 (37.05%)</td><td rowspan="1" colspan="1">5</td><td rowspan="1" colspan="1">15</td><td rowspan="1" colspan="1">2.51&#x000b1;0.25</td><td rowspan="1" colspan="1"></td></tr><tr><td rowspan="1" colspan="1"><strong>Low expression</strong></td><td rowspan="1" colspan="1">21 (39.00%)</td><td rowspan="1" colspan="1">17</td><td rowspan="1" colspan="1">4</td><td rowspan="1" colspan="1">2.04&#x000b1;0.19</td><td rowspan="1" colspan="1">P&#x0003c;0.0001</td></tr><tr><td rowspan="1" colspan="1"><strong>High expression</strong></td><td rowspan="1" colspan="1">33 (61.00%)</td><td rowspan="1" colspan="1">5</td><td rowspan="1" colspan="1">28</td><td rowspan="1" colspan="1">3.52&#x000b1;0.27</td><td rowspan="1" colspan="1"></td></tr><tr><td rowspan="1" colspan="1"><strong>Tumor size</strong></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1">P=0.3388</td></tr><tr><td rowspan="1" colspan="1">&#x0003c;4cm</td><td rowspan="1" colspan="1">23 (42.59%)</td><td rowspan="1" colspan="1">11</td><td rowspan="1" colspan="1">12</td><td rowspan="1" colspan="1">2.45&#x000b1;0.22</td><td rowspan="1" colspan="1"></td></tr><tr><td rowspan="1" colspan="1">&#x02265;4cm</td><td rowspan="1" colspan="1">31 (57.41%)</td><td rowspan="1" colspan="1">13</td><td rowspan="1" colspan="1">18</td><td rowspan="1" colspan="1">2.39&#x000b1;0.23</td><td rowspan="1" colspan="1"></td></tr></tbody></table></div><div class="largeobj-link align_right" id="largeobj_idm140460566936288"><a target="object" rel="noopener" href="/pmc/articles/PMC6367584/table/T1/?report=objectonly">Open in a separate window</a></div><div class="tblwrap-foot"><div id="fn-a.n.f.d.a"><p class="p p-first-last">Statistical analyses were performed by the Pearson &#x003c7;<sup>2</sup> test. <em>P</em> &#x0003c; 0.05 was considered as statistically significant.</p></div></div></div></div><div id="Section2" class="sec"><h3 id="Section2title">2. Effect of RRM2 knock-down on glioma using RNA-seq</h3><p class="p p-first-last">In order to characterize the function of RRM2 in glioma cell line, RNA-seq of U87 cell line on an RRM2 knock-down condition and a normal condition was designed to explore the global transcriptome changes. As a result, RNAi-mediated knock-down of RRM2 lead to 1234 up-regulated and 2276 down-regulated highly differentially expressed genes (Fig. <a href="/pmc/articles/PMC6367584/figure/F2/" target="figure" class="fig-table-link figpopup" rid-figpopup="F2" rid-ob="ob-F2" co-legend-rid="lgnd_F2"><span style="position: relative;text-decoration:none;">&#x200B;<span class="figpopup-sensitive-area" style="left: -2.5em;">(Fig.2A).</span></span><span>2</span></a>A). To investigate the most significant biological function upon knock-down, GSEA and GO enrichment analyses were performed on the whole transcriptome and highly changed genes. GSEA for the whole transcriptome demonstrated that the genes whose expression was elevated upon RRM2 knock-down were significantly enriched for regulation of substrate adhesion-dependent cell spreading, apoptotic cell clearance, negative regulation of JUN kinase activity and negative regulation of epithelial cell proliferation (Fig. <a href="/pmc/articles/PMC6367584/figure/F2/" target="figure" class="fig-table-link figpopup" rid-figpopup="F2" rid-ob="ob-F2" co-legend-rid="lgnd_F2"><span style="position: relative;text-decoration:none;">&#x200B;<span class="figpopup-sensitive-area" style="left: -2.5em;">(Fig.2B).</span></span><span>2</span></a>B). Meanwhile, as a complementary approach, GO enrichment was employed in order to improve our insight into these highly differentially expressed genes function. For up-regulated genes, cell adhesion, negative regulation of signaling, epithelial cell proliferation were the most enriched terms which have an extremely low adjusted p-value. However, positive regulation of cellular biosynthetic process has the maximum ratio of down-regulated genes and renal system development was the most significant (Fig. <a href="/pmc/articles/PMC6367584/figure/F2/" target="figure" class="fig-table-link figpopup" rid-figpopup="F2" rid-ob="ob-F2" co-legend-rid="lgnd_F2"><span style="position: relative;text-decoration:none;">&#x200B;<span class="figpopup-sensitive-area" style="left: -2.5em;">(Fig.2C).</span></span><span>2</span></a>C). We also observed that these differentially expressed genes were mainly involved in the cancer pathway (Fig. <a href="/pmc/articles/PMC6367584/figure/F2/" target="figure" class="fig-table-link figpopup" rid-figpopup="F2" rid-ob="ob-F2" co-legend-rid="lgnd_F2"><span style="position: relative;text-decoration:none;">&#x200B;<span class="figpopup-sensitive-area" style="left: -2.5em;">(Fig.2D).</span></span><span>2</span></a>D). Taken together, these results suggest that RRM2 may involve in tumorigenesis by affecting proliferation activity and apoptosis of glioma cell. Change in transcriptome indicated that the negative feedback regulation was activated upon RRM2 knock-down.</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm" id="F2" co-legend-rid="lgnd_F2"><a href="/pmc/articles/PMC6367584/figure/F2/" target="figure" rid-figpopup="F2" rid-ob="ob-F2"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div class="figure" data-largeobj="" data-largeobj-link-rid="largeobj_idm140460567627360"><a class="inline_block ts_canvas" href="/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=6367584_ijbsv15p0533g002.jpg" target="tileshopwindow" rel="noopener"><div class="ts_bar small" title="Click on image to zoom"></div><img loading="lazy" alt="An external file that holds a picture, illustration, etc.&#10;Object name is ijbsv15p0533g002.jpg" title="Click on image to zoom" class="tileshop" src="/pmc/articles/PMC6367584/bin/ijbsv15p0533g002.jpg" /></a></div><div class="largeobj-link align_right" id="largeobj_idm140460567627360"><a target="object" rel="noopener" href="/pmc/articles/PMC6367584/figure/F2/?report=objectonly">Open in a separate window</a></div></a><div class="icnblk_cntnt" id="lgnd_F2"><div><a class="figpopup" href="/pmc/articles/PMC6367584/figure/F2/" target="figure" rid-figpopup="F2" rid-ob="ob-F2">Fig 2</a></div><!--caption a7--><div class="caption"><p>Expression profile analysis of RRM2 knockdown in U87 glioma cells by RNA-Seq and bioinformatics.<strong> A</strong> Scatter plot for differentially expressed genes between RRM2 knock-down group and control. Grey points indicate the non-significant differentially expressed gene whose GFOLD value is zero. Colored points were significant differentially expressed genes (GFOLD&#x02260;0). With an additional strict cutoff of 1.3-fold change, 1234 and 2276 genes were determined as highly up- or down-regulated genes, respectively. <strong>B</strong> Differences in biological process scored by GSEA between the knock-down group and the control group. Shown are normalized enrichment scores (NES) indicating whether the GO gene sets is mobilized as a whole by RRM2 knock-down, either toward down-regulation (NES &#x0003c; 0) or toward up-regulation (NES &#x0003e; 0). <strong>C and D</strong> Gene ontology and KEGG pathway enrichment analysis which shows the distribution of terms exhibiting statistically significant differences (Fisher exact test, p-values were adjusted for multiple testing using the Benjamini-Hochberg procedure which were represented with the color scale). Only genes with at least 1.3-fold change were included to perform enrichment analysis.</p></div></div></div></div><div id="Section3" class="sec"><h3 id="Section3title">3. Knock-down of RRM2 suppresses the migration of glioma cells</h3><p class="p p-first-last">To investigate the effect of RRM2 on the migration of U87 and LN-229 cells, we used wound-healing and transwell assays. We took the representative photomicrographs of the assays every 12 hours after the monolayers scratched. Knock-down of RRM2 decreased the migration of U87 and LN-229 cells compared to the control. In addition, the transwell assay showed that the silence of RRM2 in U87 and LN-229 cells decreased the migrating cells (Fig. <a href="/pmc/articles/PMC6367584/figure/F3/" target="figure" class="fig-table-link figpopup" rid-figpopup="F3" rid-ob="ob-F3" co-legend-rid="lgnd_F3"><span style="position: relative;text-decoration:none;">&#x200B;<span class="figpopup-sensitive-area" style="left: -2.5em;">(Fig.3A-D,</span></span><span>3</span></a>A-D, Supplementary Figure <a href="#SM0" rid="SM0" class=" supplementary-material">S1</a>). To further explore the potential role of RRM2 in the migration of glioma cells, we investigated the involvement of RRM2 in regulating EMT biomarkers. Interfering with shRNAs upregulated E-cadherin levels and downregulated the levels of N-cadherin and vimentin (Fig. <a href="/pmc/articles/PMC6367584/figure/F3/" target="figure" class="fig-table-link figpopup" rid-figpopup="F3" rid-ob="ob-F3" co-legend-rid="lgnd_F3"><span style="position: relative;text-decoration:none;">&#x200B;<span class="figpopup-sensitive-area" style="left: -2.5em;">(Fig.3E-F).</span></span><span>3</span></a>E-F). Therefore, RRM2 overexpression has the potential to facilitate the migration of glioma cells.</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm" id="F3" co-legend-rid="lgnd_F3"><a href="/pmc/articles/PMC6367584/figure/F3/" target="figure" rid-figpopup="F3" rid-ob="ob-F3"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div class="figure" data-largeobj="" data-largeobj-link-rid="largeobj_idm140460567739776"><a class="inline_block ts_canvas" href="/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=6367584_ijbsv15p0533g003.jpg" target="tileshopwindow" rel="noopener"><div class="ts_bar small" title="Click on image to zoom"></div><img loading="lazy" alt="An external file that holds a picture, illustration, etc.&#10;Object name is ijbsv15p0533g003.jpg" title="Click on image to zoom" class="tileshop" src="/pmc/articles/PMC6367584/bin/ijbsv15p0533g003.jpg" /></a></div><div class="largeobj-link align_right" id="largeobj_idm140460567739776"><a target="object" rel="noopener" href="/pmc/articles/PMC6367584/figure/F3/?report=objectonly">Open in a separate window</a></div></a><div class="icnblk_cntnt" id="lgnd_F3"><div><a class="figpopup" href="/pmc/articles/PMC6367584/figure/F3/" target="figure" rid-figpopup="F3" rid-ob="ob-F3">Fig 3</a></div><!--caption a7--><div class="caption"><p>Knock-down of RRM2 inhibits the migration of glioma cells. <strong>A</strong> and <strong>C</strong> Wound-healing assays with shNC (negative control), RRM2-shRNA#1 (shRRM2#1), and RRM2-shRNA#2 (shRRM2#2) transfected U87. Migration of the cells to the wound was observed at 0, 12, and 24 h with a microscope from Carl Zeiss (Axio Observer A1; &#x000d7;200 magnification). Data shown are mean &#x000b1; SD of three independent experiments, # <em>P</em>&#x0003c; 0.001, versus shNC (negative control). <strong>B</strong> and <strong>D</strong> Knock-down of RRM2 inhibited the migration ability of U87 cells by trans-well assays; Data shown are mean &#x000b1; SD, # <em>P</em>&#x0003c; 0.001, versus shNC. <strong>E</strong> and <strong>F</strong> RRM2, E-cadherin, Vimentin, N-cadherin were detected by Western blot analysis and GAPDH was used as an internal control. data shown are mean &#x000b1; SD of three independent experiments, # <em>P</em>&#x0003c; 0.001, versus shNC.</p></div></div></div></div><div id="Section4" class="sec"><h3 id="Section4title">4. Knock-down of RRM2 discourages the proliferation of glioma cells</h3><p class="p p-first-last">Human glioma cell lines, U87, and LN-229 cells were transfected with shNC, shRRM2#1, and shRRM2#2 and the knock-down efficiency of shRNAs was validated by Western blot. As depicted in Fig. <a href="/pmc/articles/PMC6367584/figure/F4/" target="figure" class="fig-table-link figpopup" rid-figpopup="F4" rid-ob="ob-F4" co-legend-rid="lgnd_F4"><span style="position: relative;text-decoration:none;">&#x200B;<span class="figpopup-sensitive-area" style="left: -2em;">Fig.4A-B,</span></span><span>4</span></a>A-B, when RRM2 expression was knocked down with shRNAs transfection in U87 cells, the expression of cyclin A, cyclin B1 and cyclin D1 were also downregulated. Furthermore, shRNAs increased the percent of U87 cells in G2 and M phase compared with the corresponding control (shNC) shown by the flow cytometry analysis (Fig. <a href="/pmc/articles/PMC6367584/figure/F4/" target="figure" class="fig-table-link figpopup" rid-figpopup="F4" rid-ob="ob-F4" co-legend-rid="lgnd_F4"><span style="position: relative;text-decoration:none;">&#x200B;<span class="figpopup-sensitive-area" style="left: -2.5em;">(Fig.4C).</span></span><span>4</span></a>C). The CCK-8 assay also showed that knock-down of RRM2 remarkably attenuated the proliferation of U87 and LN-229 cells (Fig. <a href="/pmc/articles/PMC6367584/figure/F4/" target="figure" class="fig-table-link figpopup" rid-figpopup="F4" rid-ob="ob-F4" co-legend-rid="lgnd_F4"><span style="position: relative;text-decoration:none;">&#x200B;<span class="figpopup-sensitive-area" style="left: -2.5em;">(Fig.4D-E).</span></span><span>4</span></a>D-E). Similarly, colony formation assay proved that low expression of RRM2 interfered with shRRM2 significantly repressed the proliferation of U87 cells (Fig. <a href="/pmc/articles/PMC6367584/figure/F4/" target="figure" class="fig-table-link figpopup" rid-figpopup="F4" rid-ob="ob-F4" co-legend-rid="lgnd_F4"><span style="position: relative;text-decoration:none;">&#x200B;<span class="figpopup-sensitive-area" style="left: -2.5em;">(Fig.4F-G).</span></span><span>4</span></a>F-G). Taken together, these results suggest that downregulation of RRM2 significantly blocks the cell cycle developing from one stage to another, which leads to the inhibition of cell proliferation. Conversely, RRM2 overexpression can promote the proliferation of glioma cells.</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm" id="F4" co-legend-rid="lgnd_F4"><a href="/pmc/articles/PMC6367584/figure/F4/" target="figure" rid-figpopup="F4" rid-ob="ob-F4"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div class="figure" data-largeobj="" data-largeobj-link-rid="largeobj_idm140460564465584"><a class="inline_block ts_canvas" href="/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=6367584_ijbsv15p0533g004.jpg" target="tileshopwindow" rel="noopener"><div class="ts_bar small" title="Click on image to zoom"></div><img loading="lazy" alt="An external file that holds a picture, illustration, etc.&#10;Object name is ijbsv15p0533g004.jpg" title="Click on image to zoom" class="tileshop" src="/pmc/articles/PMC6367584/bin/ijbsv15p0533g004.jpg" /></a></div><div class="largeobj-link align_right" id="largeobj_idm140460564465584"><a target="object" rel="noopener" href="/pmc/articles/PMC6367584/figure/F4/?report=objectonly">Open in a separate window</a></div></a><div class="icnblk_cntnt" id="lgnd_F4"><div><a class="figpopup" href="/pmc/articles/PMC6367584/figure/F4/" target="figure" rid-figpopup="F4" rid-ob="ob-F4">Fig 4</a></div><!--caption a7--><div class="caption"><p>Interfering RRM2 inhibits the proliferation of cancer cells. <strong>A</strong> and <strong>B</strong> Western blot analysis showed that cyclin A, cyclin B1, and cyclin D1 were down-regulated in RRM2-transfected U87 cells. data expressed as mean &#x000b1; SD of three independent experiments, # <em>P</em>&#x0003c;0.001 and &#x00424; <em>P</em>&#x0003c;0.001, versus shNC. <strong>C</strong> RRM2 depletion significantly increased the proportion of U87 cells in G2 and M phase using flow cytometry. <strong>D</strong> and <strong>E</strong> Cell proliferation was detected by CCK-8 assay in U87 and LN229 cells; data expressed as mean &#x000b1; SD of three independent experiments, # <em>P</em>&#x0003c; 0.001 and &#x00424; <em>P</em>&#x0003c; 0.001, versus shNC. <strong>F</strong> and <strong>G</strong> Silencing of RRM2 inhibited the growth of U87 cells analyzed by colony-forming assay. The colonies were calculated. data expressed as mean &#x000b1; SD of three independent experiments, # <em>P</em>&#x0003c; 0.001 and &#x00424; <em>P</em>&#x0003c; 0.001, versus shNC.</p></div></div></div></div><div id="Section5" class="sec sec-last"><h3 id="Section5title">5. Knock-down of RRM2 inhibits proliferation of U87 cells in vivo and inactivates MAPK and AKT</h3><p class="p p-first">In this study, we found that interfering RRM2 in nude mice could reduce the growth of U87 cells significantly and result in a smaller tumor size compared with the control (Fig. <a href="/pmc/articles/PMC6367584/figure/F5/" target="figure" class="fig-table-link figpopup" rid-figpopup="F5" rid-ob="ob-F5" co-legend-rid="lgnd_F5"><span style="position: relative;text-decoration:none;">&#x200B;<span class="figpopup-sensitive-area" style="left: -2.5em;">(Fig.5A,5B).</span></span><span>5</span></a>A,5B). Furthermore, much attention should be paid to that injection with glioma cells with stably-transfected shRRM2 down-regulated the levels of cyclin B1, cyclin D1, Vimentin, N-cadherin, phospho-ERK1/2 (T202/Y204) and phospho-AKT (T308), and increased E-cadherin levels in tumors of nude mice (Fig. <a href="/pmc/articles/PMC6367584/figure/F5/" target="figure" class="fig-table-link figpopup" rid-figpopup="F5" rid-ob="ob-F5" co-legend-rid="lgnd_F5"><span style="position: relative;text-decoration:none;">&#x200B;<span class="figpopup-sensitive-area" style="left: -2.5em;">(Fig.5C,</span></span><span>5</span></a>C, 5D). Therefore, these results indicated that RRM2 knock-down can exert a strong antitumor effect <em>in vivo</em>, while RRM2 overexpression is shown to be capable of promoting tumor growth.</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm" id="F5" co-legend-rid="lgnd_F5"><a href="/pmc/articles/PMC6367584/figure/F5/" target="figure" rid-figpopup="F5" rid-ob="ob-F5"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div class="figure" data-largeobj="" data-largeobj-link-rid="largeobj_idm140460566938624"><a class="inline_block ts_canvas" href="/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=6367584_ijbsv15p0533g005.jpg" target="tileshopwindow" rel="noopener"><div class="ts_bar small" title="Click on image to zoom"></div><img loading="lazy" alt="An external file that holds a picture, illustration, etc.&#10;Object name is ijbsv15p0533g005.jpg" title="Click on image to zoom" class="tileshop" src="/pmc/articles/PMC6367584/bin/ijbsv15p0533g005.jpg" /></a></div><div class="largeobj-link align_right" id="largeobj_idm140460566938624"><a target="object" rel="noopener" href="/pmc/articles/PMC6367584/figure/F5/?report=objectonly">Open in a separate window</a></div></a><div class="icnblk_cntnt" id="lgnd_F5"><div><a class="figpopup" href="/pmc/articles/PMC6367584/figure/F5/" target="figure" rid-figpopup="F5" rid-ob="ob-F5">Fig 5</a></div><!--caption a7--><div class="caption"><p>RRM2 contributes to the proliferation of U87 cells and the activation of MAPK and AKT pathway <em>in vivo</em>. <strong>A</strong> RRM2-knock-down U87 cells were injected into nude mice and the tumors were harvested. <strong>B</strong> The volume of tumors was measured every 5 days (mean &#x000b1; SD); # p&#x0003c; 0.001 versus shNC. <strong>C</strong> and <strong>D</strong> expression of indicated proteins were analyzed by western blot. data shown are mean &#x000b1; SD, # <em>p</em>&#x0003c; 0.001 versus shNC. <strong>E</strong> and<strong> F</strong> U87 cells were transfected with plasmid used for overexpression of RRM2 protein. After 10 h transfection, the U87 cells were incubated with LY294002 (5 &#x003bc;M) or PD98059 (5 &#x003bc;M) for 12 h. Cells were then harvested for Western blot analysis. Data shown are mean &#x000b1; SD, # <em>p</em>&#x0003c; 0.001 versus shNC.</p></div></div></div><p class="p p-last">To investigate the role of AKT and MAPK in RRM2 mediated migration, proliferation, and apoptosis of glioma cells, RRM2 was overexpressed in the U87 cells. 10 h after transfection, these cells were incubated with LY294002 or PD98059. The results showed that overexpression of RRM2 significantly elevated the phosphorylation of AKT and ERK1/2. Meanwhile, we found that overexpression of RRM2 increased the expression of cyclin B1, cyclin D1, and N-cadherin, and decreased the protein levels of E-cadherin. However, the effects induced by overexpression of RRM2 were blocked by LY294002 and PD98059 obviously (Fig. <a href="/pmc/articles/PMC6367584/figure/F5/" target="figure" class="fig-table-link figpopup" rid-figpopup="F5" rid-ob="ob-F5" co-legend-rid="lgnd_F5"><span style="position: relative;text-decoration:none;">&#x200B;<span class="figpopup-sensitive-area" style="left: -2.5em;">(Fig.5E-F).</span></span><span>5</span></a>E-F). In another word, RRM2 failed to promote the migration and proliferation of U87 cells when the AKT and MAPK pathways were inhibited by LY294002 or PD98059.</p></div></div><div id="sec-a.l.d" class="tsec sec"><h2 class="head no_bottom_margin" id="sec-a.l.dtitle">Discussion</h2><p class="p p-first">Gliomas were one of the most common and serious human cancers. According to the criteria of WHO, human gliomas are classified into grade I, II, III, and IV <sup><a href="#B36" rid="B36" class=" bibr popnode">36</a></sup><sup>, </sup><sup><a href="#B37" rid="B37" class=" bibr popnode">37</a></sup>. The diffusive infiltrative and invasive characteristics of cancer cells have been the main cause of the death of glioma patients <sup><a href="#B38" rid="B38" class=" bibr popnode">38</a></sup>. Therefore, it is extremely necessary to study the molecular mechanisms of gliomas progression and prognosis. This study could offer novel targets for developing therapeutic strategies for patients with glioma.</p><p>RRM2 is often overexpressed in many kinds of cancers, such as colorectal cancer, non-small cell lung cancer (NSCLC), breast cancer, bladder cancer, ovarian cancer, pancreatic cancer, head and neck cancer and lung cancer <sup><a href="#B12" rid="B12" class=" bibr popnode">12</a></sup><sup>-</sup><sup><a href="#B16" rid="B16" class=" bibr popnode">16</a></sup>. RRM2 also can be considered as a prognostic marker for cancers including NSCLC, cervical cancer, and pancreatic cancer <sup><a href="#B17" rid="B17" class=" bibr popnode">17</a></sup><sup>-</sup><sup><a href="#B19" rid="B19" class=" bibr popnode">19</a></sup>. Additionally, RRM2 is associated with chemo-resistance during cancer treatment. Previous studies have demonstrated that suppression of RRM2 is able to efficiently increase the survival of glioma patients and improve the chemo-resistance <sup><a href="#B20" rid="B20" class=" bibr popnode">20</a></sup><sup>, </sup><sup><a href="#B21" rid="B21" class=" bibr popnode">21</a></sup>. In the current study, we found that RRM2 was highly expressed in high-grade glioma tissue, which was shown by microarray analysis and IHC. The expression of RRM2 was significantly correlated with Ki-67 (Fig. <a href="/pmc/articles/PMC6367584/figure/F1/" target="figure" class="fig-table-link figpopup" rid-figpopup="F1" rid-ob="ob-F1" co-legend-rid="lgnd_F1"><span style="position: relative;text-decoration:none;">&#x200B;<span class="figpopup-sensitive-area" style="left: -2.5em;">(Fig.1D),</span></span><span>1</span></a>D), a well-known indicator of cancer development and prognosis <sup><a href="#B39" rid="B39" class=" bibr popnode">39</a></sup>. Moreover, the data showed that low RRM2 expression exhibited better survival evidenced by microarray database. Thus, RRM2 may be a promising marker of glioma prognosis.</p><p>Nowadays, RNA-Seq was applied to comprehensively analyze the potential function of RRM2 in gliomas. RNA-Seq is a perfect method for transcriptome profiling that could offer more precise measurement of gene expressions <sup><a href="#B40" rid="B40" class=" bibr popnode">40</a></sup>. Here, we found that 1234 genes exhibited upregulated expression and 2276 genes exhibited downregulated levels in shRRM2-transfected U87 cells. The further GSEA analysis demonstrated that aberrant genes were distributed in regulation of substrate adhesion-dependent cell spreading, apoptotic cell clearance, negative regulation of JUN kinase activity and negative regulation of epithelial cell proliferation. GO terms of highly differentially expressed genes were also enriched in cell adhesion, negative regulation of signaling, epithelial cell proliferation, which were consistent with GSEA to a certain extent (Fig. <a href="/pmc/articles/PMC6367584/figure/F2/" target="figure" class="fig-table-link figpopup" rid-figpopup="F2" rid-ob="ob-F2" co-legend-rid="lgnd_F2"><span style="position: relative;text-decoration:none;">&#x200B;<span class="figpopup-sensitive-area" style="left: -2.5em;">(Fig.2</span></span><span>2</span></a>A-<a href="/pmc/articles/PMC6367584/figure/F2/" target="figure" class="fig-table-link figpopup" rid-figpopup="F2" rid-ob="ob-F2" co-legend-rid="lgnd_F2"><span style="position: relative;text-decoration:none;">&#x200B;<span class="figpopup-sensitive-area" style="left: -1em;">A-2D).</span></span><span>2</span></a>D). Together, the bioinformatics analysis indicated that a variety of biological events could be modulated by RRM2.</p><p>It has been reported that inhibition of AKT signaling always activates the intrinsic apoptotic pathway mediated by mitochondria in glioma cells <sup><a href="#B41" rid="B41" class=" bibr popnode">41</a></sup><sup>, </sup><sup><a href="#B42" rid="B42" class=" bibr popnode">42</a></sup>. Both AKT and ERK1/2 signalings play an essential role in invasion and apoptosis of glioma cells by modulating cyclin A, cyclin B1, cyclin D1, N-cadherin and E-cadherin, and cleaved caspase-3 <sup><a href="#B22" rid="B22" class=" bibr popnode">22</a></sup>. Here, the results suggested that interfering RRM2 obviously inhibited the growth of U87 cells in nude mice, and knock-down of RRM2 decreased the tumor volume (Fig. <a href="/pmc/articles/PMC6367584/figure/F5/" target="figure" class="fig-table-link figpopup" rid-figpopup="F5" rid-ob="ob-F5" co-legend-rid="lgnd_F5"><span style="position: relative;text-decoration:none;">&#x200B;<span class="figpopup-sensitive-area" style="left: -2.5em;">(Fig.5</span></span><span>5</span></a>A-<a href="/pmc/articles/PMC6367584/figure/F5/" target="figure" class="fig-table-link figpopup" rid-figpopup="F5" rid-ob="ob-F5" co-legend-rid="lgnd_F5"><span style="position: relative;text-decoration:none;">&#x200B;<span class="figpopup-sensitive-area" style="left: -1em;">A-5B).</span></span><span>5</span></a>B). In <em>in vivo</em> study, we found a downregulation in the phosphorylation of ERK1/2 and AKT, as well as the expression of cyclin B1, cyclin D and N-Cadherin. Contrarily, the levels of E-cadherin, a repressor of cell invasion, were strikingly elevated (Fig. <a href="/pmc/articles/PMC6367584/figure/F5/" target="figure" class="fig-table-link figpopup" rid-figpopup="F5" rid-ob="ob-F5" co-legend-rid="lgnd_F5"><span style="position: relative;text-decoration:none;">&#x200B;<span class="figpopup-sensitive-area" style="left: -2.5em;">(Fig.5</span></span><span>5</span></a>C-<a href="/pmc/articles/PMC6367584/figure/F5/" target="figure" class="fig-table-link figpopup" rid-figpopup="F5" rid-ob="ob-F5" co-legend-rid="lgnd_F5"><span style="position: relative;text-decoration:none;">&#x200B;<span class="figpopup-sensitive-area" style="left: -1em;">C-5D).</span></span><span>5</span></a>D). Next, overexpression of RRM2 was able to enhance the phosphorylation of AKT and ERK1/2, and increase the protein levels of their downstream targets including cyclin B1, cyclin D1, and N-cadherin. However, overexpression of RRM2 failed to upregulate the expression of cyclin B1, cyclin D1, and N-cadherin when the phosphorylation of AKT and ERK1/2 was inhibited by LY294002 or PD98059 (Fig. <a href="/pmc/articles/PMC6367584/figure/F5/" target="figure" class="fig-table-link figpopup" rid-figpopup="F5" rid-ob="ob-F5" co-legend-rid="lgnd_F5"><span style="position: relative;text-decoration:none;">&#x200B;<span class="figpopup-sensitive-area" style="left: -2.5em;">(Fig.5</span></span><span>5</span></a>E-<a href="/pmc/articles/PMC6367584/figure/F5/" target="figure" class="fig-table-link figpopup" rid-figpopup="F5" rid-ob="ob-F5" co-legend-rid="lgnd_F5"><span style="position: relative;text-decoration:none;">&#x200B;<span class="figpopup-sensitive-area" style="left: -1em;">E-5F).</span></span><span>5</span></a>F). Consequently, RRM2 regulated the invasion and apoptosis of glioma cells depending on AKT and ERK1/2 pathways, indicating that the role of RRM2 in progression and prognosis of glioma could be mediated by AKT and ERK1/2 signalings.</p><p>In <em>in vitro</em> study, we also investigated the role of RRM2 in migration, proliferation, and apoptosis of glioma cells. We found that knock-down of RRM2 suppressed the growth of glioma cells, and RRM2 may perform as a regulator of cell cycle during G2-M phase (Fig. <a href="/pmc/articles/PMC6367584/figure/F4/" target="figure" class="fig-table-link figpopup" rid-figpopup="F4" rid-ob="ob-F4" co-legend-rid="lgnd_F4"><span style="position: relative;text-decoration:none;">&#x200B;<span class="figpopup-sensitive-area" style="left: -2.5em;">(Fig.4</span></span><span>4</span></a>C-<a href="/pmc/articles/PMC6367584/figure/F4/" target="figure" class="fig-table-link figpopup" rid-figpopup="F4" rid-ob="ob-F4" co-legend-rid="lgnd_F4"><span style="position: relative;text-decoration:none;">&#x200B;<span class="figpopup-sensitive-area" style="left: -1em;">C-4G).</span></span><span>4</span></a>G). To explore the regulating mechanisms of RRM2 in cell cycle of U87 cells, we determined the expression of cyclin A, cyclin B1, and cyclin D1 (Fig. <a href="/pmc/articles/PMC6367584/figure/F4/" target="figure" class="fig-table-link figpopup" rid-figpopup="F4" rid-ob="ob-F4" co-legend-rid="lgnd_F4"><span style="position: relative;text-decoration:none;">&#x200B;<span class="figpopup-sensitive-area" style="left: -2.5em;">(Fig.4</span></span><span>4</span></a>A-<a href="/pmc/articles/PMC6367584/figure/F4/" target="figure" class="fig-table-link figpopup" rid-figpopup="F4" rid-ob="ob-F4" co-legend-rid="lgnd_F4"><span style="position: relative;text-decoration:none;">&#x200B;<span class="figpopup-sensitive-area" style="left: -1em;">A-4B),</span></span><span>4</span></a>B), which are essential regulators of cell cycle <sup><a href="#B22" rid="B22" class=" bibr popnode">22</a></sup>, and we observed that their expression was decreased after knock-down of RRM2. Meanwhile, knock-down of RRM2 significantly suppressing the migration of U87 cells evidenced by trans-well assay and wound-healing assay (Fig. <a href="/pmc/articles/PMC6367584/figure/F3/" target="figure" class="fig-table-link figpopup" rid-figpopup="F3" rid-ob="ob-F3" co-legend-rid="lgnd_F3"><span style="position: relative;text-decoration:none;">&#x200B;<span class="figpopup-sensitive-area" style="left: -2.5em;">(Fig.3</span></span><span>3</span></a>A-<a href="/pmc/articles/PMC6367584/figure/F3/" target="figure" class="fig-table-link figpopup" rid-figpopup="F3" rid-ob="ob-F3" co-legend-rid="lgnd_F3"><span style="position: relative;text-decoration:none;">&#x200B;<span class="figpopup-sensitive-area" style="left: -1em;">A-3D).</span></span><span>3</span></a>D). Knock-down of RRM2 also significantly elevated the expression of E-cadherin (Fig. <a href="/pmc/articles/PMC6367584/figure/F3/" target="figure" class="fig-table-link figpopup" rid-figpopup="F3" rid-ob="ob-F3" co-legend-rid="lgnd_F3"><span style="position: relative;text-decoration:none;">&#x200B;<span class="figpopup-sensitive-area" style="left: -2.5em;">(Fig.3</span></span><span>3</span></a>E-<a href="/pmc/articles/PMC6367584/figure/F3/" target="figure" class="fig-table-link figpopup" rid-figpopup="F3" rid-ob="ob-F3" co-legend-rid="lgnd_F3"><span style="position: relative;text-decoration:none;">&#x200B;<span class="figpopup-sensitive-area" style="left: -1em;">E-3F),</span></span><span>3</span></a>F), a suppressor of glioma development and invasion <sup><a href="#B43" rid="B43" class=" bibr popnode">43</a></sup>. Additionally, more apoptotic cells were detected by flow cytometry in the shRRM2-transfected cells than the negative control, accompanied by upregulation of cleaved caspase-3 and downregulation of BCL-2 (Fig. <a href="/pmc/articles/PMC6367584/figure/F3/" target="figure" class="fig-table-link figpopup" rid-figpopup="F3" rid-ob="ob-F3" co-legend-rid="lgnd_F3"><span style="position: relative;text-decoration:none;">&#x200B;<span class="figpopup-sensitive-area" style="left: -2.5em;">(Fig.3</span></span><span>3</span></a>E-<a href="/pmc/articles/PMC6367584/figure/F3/" target="figure" class="fig-table-link figpopup" rid-figpopup="F3" rid-ob="ob-F3" co-legend-rid="lgnd_F3"><span style="position: relative;text-decoration:none;">&#x200B;<span class="figpopup-sensitive-area" style="left: -1em;">E-3F),</span></span><span>3</span></a>F), indicating that an important role of RRM2 in balancing apoptosis and proliferation.</p><p class="p p-last">In conclusion, RRM2 plays an important role in many molecular pathological processes evidenced by RNA-Seq. RRM2 enhances growth, migration and inhibits apoptosis of glioma cells <em>in vivo</em> and <em>in vitro</em> through upregulating phosphorylation of ERK1/2 and AKT. Suppression of RRM2 may be considered as a potential target for the treatment of RRM2-overexpressing gliomas.</p></div><div id="SM0" class="tsec sec"><a id="supplementary-material-sec"></a><h2 class="head no_bottom_margin" id="SM0title">Supplementary Material</h2><!--/article/body/sec/--><div class="sec suppmat" id="SM1"><p>Supplementary figures.</p><div class="sup-box half_rhythm" id="media-a.l.e.b.b"><a href="/pmc/articles/PMC6367584/bin/ijbsv15p0533s1.pdf" data-ga-action="click_feat_suppl">Click here for additional data file.</a><sup>(813K, pdf)</sup></div></div><div class="sec suppmat" id="SM2"><p>Supplementary table.</p><div class="sup-box half_rhythm" id="media-a.l.e.c.b"><a href="/pmc/articles/PMC6367584/bin/ijbsv15p0533s2.xlsx" data-ga-action="click_feat_suppl">Click here for additional data file.</a><sup>(807K, xlsx)</sup></div></div></div><div id="ack-a.m.a" class="tsec sec"><h2 class="head no_bottom_margin" id="ack-a.m.atitle">Authors' contributions</h2><div class="sec"><div id="sec-a.m.a.a" class="sec sec-first"><h3 id="sec-a.m.a.atitle"></h3><p class="p p-first-last">Y.B.Y. and J.M.J. conceived and designed the experiments. S.H.Z., Z.H., Y.B.Y., S.J.W., Z.Y.N., X.T.Y., Y.Z.N., X.J.C. and Y.Z.H. carried out the experiments. Y.B.Y., Z.H. and X.Z.P. analyzed the data. H.M. contributed the reagents and materials. S.H.Z., Z.H., Y.B.Y., J.M.J., W.C.Y., and Z.Y.S drafted the manuscript. All authors reviewed the final manuscript.</p></div><div id="sec-a.m.a.b" class="sec"><h3 id="sec-a.m.a.btitle">Funding</h3><p class="p p-first-last">This project was sponsored by Nanjing Medical University (2013NJMU008, 13JC007).</p></div><div id="sec-a.m.a.c" class="sec sec-last"><h3 id="sec-a.m.a.ctitle">Declarations</h3><p class="p p-first-last">Ethics approval and consent to participate: all the experimental procedures were approved by the animal care committee of Nanjing Medical University, Nanjing, Jiangsu, 211166, China. Consent for publication: This manuscript has been approved by all authors for publication.</p></div></div></div><div id="ref-list-a.m.b" class="tsec sec"><h2 class="head no_bottom_margin" id="ref-list-a.m.btitle">References</h2><div class="ref-list-sec sec" id="reference-list"><div class="ref-cit-blk half_rhythm" id="B1">1. <span class="element-citation">Porter KR, McCarthy BJ, Freels S, Kim Y, Davis FG. Prevalence estimates for primary brain tumors in the United States by age, gender, behavior, and histology. <span><span class="ref-journal">Neuro-Oncology. </span>2010;<span class="ref-vol">12</span>:520–7.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2940648/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/20511189" ref="reftype=pubmed&amp;article-id=6367584&amp;issue-id=329202&amp;journal-id=294&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Neuro-Oncology&amp;title=Prevalence+estimates+for+primary+brain+tumors+in+the+United+States+by+age,+gender,+behavior,+and+histology&amp;author=KR+Porter&amp;author=BJ+McCarthy&amp;author=S+Freels&amp;author=Y+Kim&amp;author=FG+Davis&amp;volume=12&amp;publication_year=2010&amp;pages=520-7&amp;pmid=20511189&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=6367584&amp;issue-id=329202&amp;journal-id=294&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B2">2. <span class="element-citation">Jiang T, Tang GF, Lin Y, Peng XX, Zhang X, Zhai XW. et al. Prevalence estimates for primary brain tumors in China: a multi-center cross-sectional study. <span><span class="ref-journal">Chinese Med J-Peking. </span>2011;<span class="ref-vol">124</span>:2578–83.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/22040406" ref="reftype=pubmed&amp;article-id=6367584&amp;issue-id=329202&amp;journal-id=294&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Chinese+Med+J-Peking&amp;title=Prevalence+estimates+for+primary+brain+tumors+in+China:+a+multi-center+cross-sectional+study&amp;author=T+Jiang&amp;author=GF+Tang&amp;author=Y+Lin&amp;author=XX+Peng&amp;author=X+Zhang&amp;volume=124&amp;publication_year=2011&amp;pages=2578-83&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=6367584&amp;issue-id=329202&amp;journal-id=294&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B3">3. <span class="element-citation">Ostrom QT, Gittleman H, Xu J, Kromer C, Wolinsky Y, Kruchko C. et al. CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2009-2013. <span><span class="ref-journal">Neuro-Oncology. </span>2016;<span class="ref-vol">18</span>:v1–v75.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC8483569/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/28475809" ref="reftype=pubmed&amp;article-id=6367584&amp;issue-id=329202&amp;journal-id=294&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Neuro-Oncology&amp;title=CBTRUS+Statistical+Report:+Primary+Brain+and+Other+Central+Nervous+System+Tumors+Diagnosed+in+the+United+States+in+2009-2013&amp;author=QT+Ostrom&amp;author=H+Gittleman&amp;author=J+Xu&amp;author=C+Kromer&amp;author=Y+Wolinsky&amp;volume=18&amp;publication_year=2016&amp;pages=v1-v75&amp;pmid=28475809&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=6367584&amp;issue-id=329202&amp;journal-id=294&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B4">4. <span class="element-citation">Tanaka S, Louis DN, Curry WT, Batchelor TT, Dietrich J. Diagnostic and therapeutic avenues for glioblastoma: no longer a dead end? <span><span class="ref-journal">Nat Rev Clin Oncol. </span>2013;<span class="ref-vol">10</span>:14–26.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/23183634" ref="reftype=pubmed&amp;article-id=6367584&amp;issue-id=329202&amp;journal-id=294&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nat+Rev+Clin+Oncol&amp;title=Diagnostic+and+therapeutic+avenues+for+glioblastoma:+no+longer+a+dead+end?&amp;author=S+Tanaka&amp;author=DN+Louis&amp;author=WT+Curry&amp;author=TT+Batchelor&amp;author=J+Dietrich&amp;volume=10&amp;publication_year=2013&amp;pages=14-26&amp;pmid=23183634&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=6367584&amp;issue-id=329202&amp;journal-id=294&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B5">5. <span class="element-citation">Bartek J, Mistrik M, Bartkova J. Thresholds of replication stress signaling in cancer development and treatment. <span><span class="ref-journal">Nat Struct Mol Biol. </span>2012;<span class="ref-vol">19</span>:5–7.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/22218289" ref="reftype=pubmed&amp;article-id=6367584&amp;issue-id=329202&amp;journal-id=294&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nat+Struct+Mol+Biol&amp;title=Thresholds+of+replication+stress+signaling+in+cancer+development+and+treatment&amp;author=J+Bartek&amp;author=M+Mistrik&amp;author=J+Bartkova&amp;volume=19&amp;publication_year=2012&amp;pages=5-7&amp;pmid=22218289&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=6367584&amp;issue-id=329202&amp;journal-id=294&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B6">6. <span class="element-citation">Cloughesy TF, Cavenee WK, Mischel PS. Glioblastoma: From Molecular Pathology to Targeted Treatment. <span><span class="ref-journal">Annu Rev Pathol-Mech. </span>2014;<span class="ref-vol">9</span>:1–25.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/23937436" ref="reftype=pubmed&amp;article-id=6367584&amp;issue-id=329202&amp;journal-id=294&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Annu+Rev+Pathol-Mech&amp;title=Glioblastoma:+From+Molecular+Pathology+to+Targeted+Treatment&amp;author=TF+Cloughesy&amp;author=WK+Cavenee&amp;author=PS+Mischel&amp;volume=9&amp;publication_year=2014&amp;pages=1-25&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=6367584&amp;issue-id=329202&amp;journal-id=294&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B7">7. <span class="element-citation">Meyer MA. Malignant gliomas in adults. <span><span class="ref-journal">New Engl J Med. </span>2008;<span class="ref-vol">359</span>:1850.</span> - [<a href="https://pubmed.ncbi.nlm.nih.gov/18946076" ref="reftype=pubmed&amp;article-id=6367584&amp;issue-id=329202&amp;journal-id=294&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=New+Engl+J+Med&amp;title=Malignant+gliomas+in+adults&amp;author=MA+Meyer&amp;volume=359&amp;publication_year=2008&amp;pages=1850&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=6367584&amp;issue-id=329202&amp;journal-id=294&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B8">8. <span class="element-citation">Vehlow A, Cordes N. Invasion as target for therapy of glioblastoma multiforme. <span><span class="ref-journal">Bba-Rev Cancer. </span>2013;<span class="ref-vol">1836</span>:236–44.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/23891970" ref="reftype=pubmed&amp;article-id=6367584&amp;issue-id=329202&amp;journal-id=294&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Bba-Rev+Cancer&amp;title=Invasion+as+target+for+therapy+of+glioblastoma+multiforme&amp;author=A+Vehlow&amp;author=N+Cordes&amp;volume=1836&amp;publication_year=2013&amp;pages=236-44&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=6367584&amp;issue-id=329202&amp;journal-id=294&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B9">9. <span class="element-citation">Torrents E, Aloy P, Gibert I, Rodriguez-Trelles F. Ribonucleotide reductases: Divergent evolution of an ancient enzyme. <span><span class="ref-journal">J Mol Evol. </span>2002;<span class="ref-vol">55</span>:138–52.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/12107591" ref="reftype=pubmed&amp;article-id=6367584&amp;issue-id=329202&amp;journal-id=294&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Mol+Evol&amp;title=Ribonucleotide+reductases:+Divergent+evolution+of+an+ancient+enzyme&amp;author=E+Torrents&amp;author=P+Aloy&amp;author=I+Gibert&amp;author=F+Rodriguez-Trelles&amp;volume=55&amp;publication_year=2002&amp;pages=138-52&amp;pmid=12107591&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=6367584&amp;issue-id=329202&amp;journal-id=294&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B10">10. <span class="element-citation">Chabes A, Thelander L. Controlled protein degradation regulates ribonucleotide reductase activity in proliferating mammalian cells during the normal cell cycle and in response to DNA damage and replication blocks. <span><span class="ref-journal">J Biol Chem. </span>2000;<span class="ref-vol">275</span>:17747–53.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/10747958" ref="reftype=pubmed&amp;article-id=6367584&amp;issue-id=329202&amp;journal-id=294&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Biol+Chem&amp;title=Controlled+protein+degradation+regulates+ribonucleotide+reductase+activity+in+proliferating+mammalian+cells+during+the+normal+cell+cycle+and+in+response+to+DNA+damage+and+replication+blocks&amp;author=A+Chabes&amp;author=L+Thelander&amp;volume=275&amp;publication_year=2000&amp;pages=17747-53&amp;pmid=10747958&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=6367584&amp;issue-id=329202&amp;journal-id=294&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B11">11. <span class="element-citation">Nordlund N, Reichard P. Ribonucleotide reductases. <span><span class="ref-journal">Annu Rev Biochem. </span>2006;<span class="ref-vol">75</span>:681–706.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/16756507" ref="reftype=pubmed&amp;article-id=6367584&amp;issue-id=329202&amp;journal-id=294&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Annu+Rev+Biochem&amp;title=Ribonucleotide+reductases&amp;author=N+Nordlund&amp;author=P+Reichard&amp;volume=75&amp;publication_year=2006&amp;pages=681-706&amp;pmid=16756507&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=6367584&amp;issue-id=329202&amp;journal-id=294&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B12">12. <span class="element-citation">Morikawa T, Maeda D, Kume H, Homma Y, Fukayama M. Ribonucleotide reductase M2 subunit is a novel diagnostic marker and a potential therapeutic target in bladder cancer. <span><span class="ref-journal">Histopathology. </span>2010;<span class="ref-vol">57</span>:885–92.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/21166702" ref="reftype=pubmed&amp;article-id=6367584&amp;issue-id=329202&amp;journal-id=294&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Histopathology&amp;title=Ribonucleotide+reductase+M2+subunit+is+a+novel+diagnostic+marker+and+a+potential+therapeutic+target+in+bladder+cancer&amp;author=T+Morikawa&amp;author=D+Maeda&amp;author=H+Kume&amp;author=Y+Homma&amp;author=M+Fukayama&amp;volume=57&amp;publication_year=2010&amp;pages=885-92&amp;pmid=21166702&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=6367584&amp;issue-id=329202&amp;journal-id=294&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B13">13. <span class="element-citation">Liu XY, Zhou BS, Xue LJ, Yen F, Chu PG, Un F. et al. Ribonucleotide reductase subunits M2 and p53R2 are potential biomarkers for metastasis of colon cancer. <span><span class="ref-journal">Clin Colorectal Cancer. </span>2007;<span class="ref-vol">6</span>:374–81.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/17311703" ref="reftype=pubmed&amp;article-id=6367584&amp;issue-id=329202&amp;journal-id=294&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Clin+Colorectal+Cancer&amp;title=Ribonucleotide+reductase+subunits+M2+and+p53R2+are+potential+biomarkers+for+metastasis+of+colon+cancer&amp;author=XY+Liu&amp;author=BS+Zhou&amp;author=LJ+Xue&amp;author=F+Yen&amp;author=PG+Chu&amp;volume=6&amp;publication_year=2007&amp;pages=374-81&amp;pmid=17311703&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=6367584&amp;issue-id=329202&amp;journal-id=294&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B14">14. <span class="element-citation">Rahman MA, Amin RMR, Wang DS, Koenig L, Nannapaneni S, Chen ZJ. et al. RRM2 Regulates Bcl-2 in Head and Neck and Lung Cancers: A Potential Target for Cancer Therapy. <span><span class="ref-journal">Clin Cancer Res. </span>2013;<span class="ref-vol">19</span>:3416–28.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC3747783/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/23719266" ref="reftype=pubmed&amp;article-id=6367584&amp;issue-id=329202&amp;journal-id=294&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Clin+Cancer+Res&amp;title=RRM2+Regulates+Bcl-2+in+Head+and+Neck+and+Lung+Cancers:+A+Potential+Target+for+Cancer+Therapy&amp;author=MA+Rahman&amp;author=RMR+Amin&amp;author=DS+Wang&amp;author=L+Koenig&amp;author=S+Nannapaneni&amp;volume=19&amp;publication_year=2013&amp;pages=3416-28&amp;pmid=23719266&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=6367584&amp;issue-id=329202&amp;journal-id=294&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B15">15. <span class="element-citation">Yoshida Y, Tsunoda T, Doi K, Tanaka Y, Fujimoto T, Machida T. et al. KRAS-mediated Up-regulation of RRM2 Expression Is Essential for the Proliferation of Colorectal Cancer Cell Lines. <span><span class="ref-journal">Anticancer Res. </span>2011;<span class="ref-vol">31</span>:2535–9.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/21873171" ref="reftype=pubmed&amp;article-id=6367584&amp;issue-id=329202&amp;journal-id=294&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Anticancer+Res&amp;title=KRAS-mediated+Up-regulation+of+RRM2+Expression+Is+Essential+for+the+Proliferation+of+Colorectal+Cancer+Cell+Lines&amp;author=Y+Yoshida&amp;author=T+Tsunoda&amp;author=K+Doi&amp;author=Y+Tanaka&amp;author=T+Fujimoto&amp;volume=31&amp;publication_year=2011&amp;pages=2535-9&amp;pmid=21873171&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=6367584&amp;issue-id=329202&amp;journal-id=294&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B16">16. <span class="element-citation">Xia GG, Wang HC, Song ZL, Meng QC, Huang XY, Huang XY.  <span class="ref-journal">Gambogic acid sensitizes gemcitabine efficacy in pancreatic cancer by reducing the expression of ribonucleotide reductase subunit-M2 (RRM2)</span> J Exp Clin Cancer Res; 2017. p. 36. <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC5553806/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/28797284" ref="reftype=pubmed&amp;article-id=6367584&amp;issue-id=329202&amp;journal-id=294&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?title=Gambogic+acid+sensitizes+gemcitabine+efficacy+in+pancreatic+cancer+by+reducing+the+expression+of+ribonucleotide+reductase+subunit-M2+(RRM2)&amp;author=GG+Xia&amp;author=HC+Wang&amp;author=ZL+Song&amp;author=QC+Meng&amp;author=XY+Huang&amp;publication_year=2017&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=6367584&amp;issue-id=329202&amp;journal-id=294&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B17">17. <span class="element-citation">Su YF, Wu TF, Ko JL, Tsai HT, Tee YT, Chien MH,  <span class="ref-journal">The Expression of Ribonucleotide Reductase M2 in the Carcinogenesis of Uterine Cervix and Its Relationship with Clinicopathological Characteristics and Prognosis of Cancer Patients.</span> PLoS One; 2014. p. 9. <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC3956764/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/24637958" ref="reftype=pubmed&amp;article-id=6367584&amp;issue-id=329202&amp;journal-id=294&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?title=The+Expression+of+Ribonucleotide+Reductase+M2+in+the+Carcinogenesis+of+Uterine+Cervix+and+Its+Relationship+with+Clinicopathological+Characteristics+and+Prognosis+of+Cancer+Patients&amp;author=YF+Su&amp;author=TF+Wu&amp;author=JL+Ko&amp;author=HT+Tsai&amp;author=YT+Tee&amp;publication_year=2014&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=6367584&amp;issue-id=329202&amp;journal-id=294&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B18">18. <span class="element-citation">Mah V, Alavi M, Marquez-Garban DC, Maresh EL, Kim SR, Horvath S,  <span class="ref-journal">Ribonucleotide Reductase Subunit M2 Predicts Survival in Subgroups of Patients with Non-Small Cell Lung Carcinoma: Effects of Gender and Smoking Status.</span> PLoS One; 2015. p. 10. <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC4441434/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/26001082" ref="reftype=pubmed&amp;article-id=6367584&amp;issue-id=329202&amp;journal-id=294&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?title=Ribonucleotide+Reductase+Subunit+M2+Predicts+Survival+in+Subgroups+of+Patients+with+Non-Small+Cell+Lung+Carcinoma:+Effects+of+Gender+and+Smoking+Status&amp;author=V+Mah&amp;author=M+Alavi&amp;author=DC+Marquez-Garban&amp;author=EL+Maresh&amp;author=SR+Kim&amp;publication_year=2015&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=6367584&amp;issue-id=329202&amp;journal-id=294&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B19">19. <span class="element-citation">Wang L, Meng L, Wang XW, Ma GY, Chen JH. Expression of RRM1 and RRM2 as a novel prognostic marker in advanced non-small cell lung cancer receiving chemotherapy. <span><span class="ref-journal">Tumor Biol. </span>2014;<span class="ref-vol">35</span>:1899–906.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/24155212" ref="reftype=pubmed&amp;article-id=6367584&amp;issue-id=329202&amp;journal-id=294&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Tumor+Biol&amp;title=Expression+of+RRM1+and+RRM2+as+a+novel+prognostic+marker+in+advanced+non-small+cell+lung+cancer+receiving+chemotherapy&amp;author=L+Wang&amp;author=L+Meng&amp;author=XW+Wang&amp;author=GY+Ma&amp;author=JH+Chen&amp;volume=35&amp;publication_year=2014&amp;pages=1899-906&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=6367584&amp;issue-id=329202&amp;journal-id=294&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B20">20. <span class="element-citation">Wu P, Dugoua JJ, Eyawo O, Mills EJ.  <span class="ref-journal">Traditional Chinese medicines in the treatment of hepatocellular cancers: a systematic review and meta-analysis.</span> J Exp Clin Cancer Res; 2009. p. 28. <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC3225807/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/19674474" ref="reftype=pubmed&amp;article-id=6367584&amp;issue-id=329202&amp;journal-id=294&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?title=Traditional+Chinese+medicines+in+the+treatment+of+hepatocellular+cancers:+a+systematic+review+and+meta-analysis&amp;author=P+Wu&amp;author=JJ+Dugoua&amp;author=O+Eyawo&amp;author=EJ+Mills&amp;publication_year=2009&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=6367584&amp;issue-id=329202&amp;journal-id=294&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B21">21. <span class="element-citation">Wang ZJ, Liu XF, Ho RLKY, Lam CWK, Chow MSS.  <span class="ref-journal">Precision or Personalized Medicine for Cancer Chemotherapy: Is there a Role for Herbal Medicine.</span> Molecules; 2016. p. 21. <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC6273869/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/27399658" ref="reftype=pubmed&amp;article-id=6367584&amp;issue-id=329202&amp;journal-id=294&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?title=Precision+or+Personalized+Medicine+for+Cancer+Chemotherapy:+Is+there+a+Role+for+Herbal+Medicine&amp;author=ZJ+Wang&amp;author=XF+Liu&amp;author=RLKY+Ho&amp;author=CWK+Lam&amp;author=MSS+Chow&amp;publication_year=2016&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=6367584&amp;issue-id=329202&amp;journal-id=294&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B22">22. <span class="element-citation">Pan YY, Zhang YL, Chen LJ, Liu Y, Feng YL, Yan JY. The Critical Role of Rab31 in Cell Proliferation and Apoptosis in Cancer Progression. <span><span class="ref-journal">Mol Neurobiol. </span>2016;<span class="ref-vol">53</span>:4431–7.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/26245486" ref="reftype=pubmed&amp;article-id=6367584&amp;issue-id=329202&amp;journal-id=294&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Mol+Neurobiol&amp;title=The+Critical+Role+of+Rab31+in+Cell+Proliferation+and+Apoptosis+in+Cancer+Progression&amp;author=YY+Pan&amp;author=YL+Zhang&amp;author=LJ+Chen&amp;author=Y+Liu&amp;author=YL+Feng&amp;volume=53&amp;publication_year=2016&amp;pages=4431-7&amp;pmid=26245486&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=6367584&amp;issue-id=329202&amp;journal-id=294&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B23">23. <span class="element-citation">Colaprico A, Silva TC, Olsen C, Garofano L, Cava C, Garolini D. et al. TCGAbiolinks: an R/Bioconductor package for integrative analysis of TCGA data. <span><span class="ref-journal">Nucleic Acids Res. </span>2016;<span class="ref-vol">44</span>:e71.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC4856967/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/26704973" ref="reftype=pubmed&amp;article-id=6367584&amp;issue-id=329202&amp;journal-id=294&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nucleic+Acids+Res&amp;title=TCGAbiolinks:+an+R/Bioconductor+package+for+integrative+analysis+of+TCGA+data&amp;author=A+Colaprico&amp;author=TC+Silva&amp;author=C+Olsen&amp;author=L+Garofano&amp;author=C+Cava&amp;volume=44&amp;publication_year=2016&amp;pages=e71&amp;pmid=26704973&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=6367584&amp;issue-id=329202&amp;journal-id=294&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B24">24. <span class="element-citation">Amelio I, Tsvetkov PO, Knight RA, Lisitsa A, Melino G, Antonov AV. SynTarget: an online tool to test the synergetic effect of genes on survival outcome in cancer. <span><span class="ref-journal">Cell Death Differ. </span>2016;<span class="ref-vol">23</span>:912.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC4832110/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/26915292" ref="reftype=pubmed&amp;article-id=6367584&amp;issue-id=329202&amp;journal-id=294&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Cell+Death+Differ&amp;title=SynTarget:+an+online+tool+to+test+the+synergetic+effect+of+genes+on+survival+outcome+in+cancer&amp;author=I+Amelio&amp;author=PO+Tsvetkov&amp;author=RA+Knight&amp;author=A+Lisitsa&amp;author=G+Melino&amp;volume=23&amp;publication_year=2016&amp;pages=912&amp;pmid=26915292&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=6367584&amp;issue-id=329202&amp;journal-id=294&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B25">25. <span class="element-citation">Wu AB, Wu B, Guo JS, Luo WR, Wu D, Yang HL,  <span class="ref-journal">Elevated expression of CDK4 in lung cancer.</span> J Transl Med; 2011. p. 9. <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC3094221/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/21477379" ref="reftype=pubmed&amp;article-id=6367584&amp;issue-id=329202&amp;journal-id=294&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?title=Elevated+expression+of+CDK4+in+lung+cancer&amp;author=AB+Wu&amp;author=B+Wu&amp;author=JS+Guo&amp;author=WR+Luo&amp;author=D+Wu&amp;publication_year=2011&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=6367584&amp;issue-id=329202&amp;journal-id=294&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B26">26. <span class="element-citation">Chen S, Zhou Y, Chen Y, Gu J. fastp: an ultra-fast all-in-one FASTQ preprocessor. <span><span class="ref-journal">Bioinformatics. </span>2018;<span class="ref-vol">34</span>:i884–i90.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC6129281/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/30423086" ref="reftype=pubmed&amp;article-id=6367584&amp;issue-id=329202&amp;journal-id=294&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Bioinformatics&amp;title=fastp:+an+ultra-fast+all-in-one+FASTQ+preprocessor&amp;author=S+Chen&amp;author=Y+Zhou&amp;author=Y+Chen&amp;author=J+Gu&amp;volume=34&amp;publication_year=2018&amp;pages=i884-i90&amp;pmid=30423086&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=6367584&amp;issue-id=329202&amp;journal-id=294&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B27">27. <span class="element-citation">Kopylova E, Noe L, Touzet H. SortMeRNA: fast and accurate filtering of ribosomal RNAs in metatranscriptomic data. <span><span class="ref-journal">Bioinformatics. </span>2012;<span class="ref-vol">28</span>:3211–7.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/23071270" ref="reftype=pubmed&amp;article-id=6367584&amp;issue-id=329202&amp;journal-id=294&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Bioinformatics&amp;title=SortMeRNA:+fast+and+accurate+filtering+of+ribosomal+RNAs+in+metatranscriptomic+data&amp;author=E+Kopylova&amp;author=L+Noe&amp;author=H+Touzet&amp;volume=28&amp;publication_year=2012&amp;pages=3211-7&amp;pmid=23071270&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=6367584&amp;issue-id=329202&amp;journal-id=294&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B28">28. <span class="element-citation">Kim D, Langmead B, Salzberg SL. HISAT: a fast spliced aligner with low memory requirements. <span><span class="ref-journal">Nat Methods. </span>2015;<span class="ref-vol">12</span>:357–60.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC4655817/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/25751142" ref="reftype=pubmed&amp;article-id=6367584&amp;issue-id=329202&amp;journal-id=294&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nat+Methods&amp;title=HISAT:+a+fast+spliced+aligner+with+low+memory+requirements&amp;author=D+Kim&amp;author=B+Langmead&amp;author=SL+Salzberg&amp;volume=12&amp;publication_year=2015&amp;pages=357-60&amp;pmid=25751142&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=6367584&amp;issue-id=329202&amp;journal-id=294&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B29">29. <span class="element-citation">Feng J, Meyer CA, Wang Q, Liu JS, Shirley Liu X, Zhang Y. GFOLD: a generalized fold change for ranking differentially expressed genes from RNA-seq data. <span><span class="ref-journal">Bioinformatics. </span>2012;<span class="ref-vol">28</span>:2782–8.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/22923299" ref="reftype=pubmed&amp;article-id=6367584&amp;issue-id=329202&amp;journal-id=294&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Bioinformatics&amp;title=GFOLD:+a+generalized+fold+change+for+ranking+differentially+expressed+genes+from+RNA-seq+data&amp;author=J+Feng&amp;author=CA+Meyer&amp;author=Q+Wang&amp;author=JS+Liu&amp;author=X+Shirley+Liu&amp;volume=28&amp;publication_year=2012&amp;pages=2782-8&amp;pmid=22923299&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=6367584&amp;issue-id=329202&amp;journal-id=294&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B30">30. <span class="element-citation">Yu G, Wang LG, Han Y, He QY. clusterProfiler: an R package for comparing biological themes among gene clusters. <span><span class="ref-journal">OMICS. </span>2012;<span class="ref-vol">16</span>:284–7.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC3339379/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/22455463" ref="reftype=pubmed&amp;article-id=6367584&amp;issue-id=329202&amp;journal-id=294&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=OMICS&amp;title=clusterProfiler:+an+R+package+for+comparing+biological+themes+among+gene+clusters&amp;author=G+Yu&amp;author=LG+Wang&amp;author=Y+Han&amp;author=QY+He&amp;volume=16&amp;publication_year=2012&amp;pages=284-7&amp;pmid=22455463&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=6367584&amp;issue-id=329202&amp;journal-id=294&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B31">31. <span class="element-citation">Ito K, Murphy D. Application of ggplot2 to Pharmacometric Graphics. <span><span class="ref-journal">CPT Pharmacometrics Syst Pharmacol. </span>2013;<span class="ref-vol">2</span>:e79.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC3817376/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/24132163" ref="reftype=pubmed&amp;article-id=6367584&amp;issue-id=329202&amp;journal-id=294&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=CPT+Pharmacometrics+Syst+Pharmacol&amp;title=Application+of+ggplot2+to+Pharmacometric+Graphics&amp;author=K+Ito&amp;author=D+Murphy&amp;volume=2&amp;publication_year=2013&amp;pages=e79&amp;pmid=24132163&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=6367584&amp;issue-id=329202&amp;journal-id=294&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B32">32. <span class="element-citation">Fiebig HH, Berger DP, Winterhalter BR, Plowman J. In vitro and in vivo evaluation of US-NCI compounds in human tumor xenografts. <span><span class="ref-journal">Cancer treatment reviews. </span>1990;<span class="ref-vol">17</span>:109–17.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/2272027" ref="reftype=pubmed&amp;article-id=6367584&amp;issue-id=329202&amp;journal-id=294&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Cancer+treatment+reviews&amp;title=In+vitro+and+in+vivo+evaluation+of+US-NCI+compounds+in+human+tumor+xenografts&amp;author=HH+Fiebig&amp;author=DP+Berger&amp;author=BR+Winterhalter&amp;author=J+Plowman&amp;volume=17&amp;publication_year=1990&amp;pages=109-17&amp;pmid=2272027&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=6367584&amp;issue-id=329202&amp;journal-id=294&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B33">33. <span class="element-citation">Zhang H, Liu XY, Warden CD, Huang YS, Loera S, Xue LJ,  <span class="ref-journal">Prognostic and therapeutic significance of ribonucleotide reductase small subunit M2 in estrogen-negative breast cancers.</span> BMC Cancer; 2014. p. 14. <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC4171582/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/25213022" ref="reftype=pubmed&amp;article-id=6367584&amp;issue-id=329202&amp;journal-id=294&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?title=Prognostic+and+therapeutic+significance+of+ribonucleotide+reductase+small+subunit+M2+in+estrogen-negative+breast+cancers&amp;author=H+Zhang&amp;author=XY+Liu&amp;author=CD+Warden&amp;author=YS+Huang&amp;author=S+Loera&amp;publication_year=2014&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=6367584&amp;issue-id=329202&amp;journal-id=294&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B34">34. <span class="element-citation">Zhao H, Zhang HW, Du YH, Gu XM. Prognostic significance of BRCA1, ERCC1, RRM1, and RRM2 in patients with advanced non-small cell lung cancer receiving chemotherapy. <span><span class="ref-journal">Tumor Biol. </span>2014;<span class="ref-vol">35</span>:12679–88.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/25227663" ref="reftype=pubmed&amp;article-id=6367584&amp;issue-id=329202&amp;journal-id=294&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Tumor+Biol&amp;title=Prognostic+significance+of+BRCA1,+ERCC1,+RRM1,+and+RRM2+in+patients+with+advanced+non-small+cell+lung+cancer+receiving+chemotherapy&amp;author=H+Zhao&amp;author=HW+Zhang&amp;author=YH+Du&amp;author=XM+Gu&amp;volume=35&amp;publication_year=2014&amp;pages=12679-88&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=6367584&amp;issue-id=329202&amp;journal-id=294&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B35">35. <span class="element-citation">Tang H, Xiao GH, Behrens C, Schiller J, Allen J, Chow CW. et al. A 12-Gene Set Predicts Survival Benefits from Adjuvant Chemotherapy in Non-Small Cell Lung Cancer Patients. <span><span class="ref-journal">Clin Cancer Res. </span>2013;<span class="ref-vol">19</span>:1577–86.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC3619002/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/23357979" ref="reftype=pubmed&amp;article-id=6367584&amp;issue-id=329202&amp;journal-id=294&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Clin+Cancer+Res&amp;title=A+12-Gene+Set+Predicts+Survival+Benefits+from+Adjuvant+Chemotherapy+in+Non-Small+Cell+Lung+Cancer+Patients&amp;author=H+Tang&amp;author=GH+Xiao&amp;author=C+Behrens&amp;author=J+Schiller&amp;author=J+Allen&amp;volume=19&amp;publication_year=2013&amp;pages=1577-86&amp;pmid=23357979&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=6367584&amp;issue-id=329202&amp;journal-id=294&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B36">36. <span class="element-citation">Hollon T, Hervey-Jumper SL, Sagher O, Orringer DA. Advances in the Surgical Management of Low-Grade Glioma. <span><span class="ref-journal">Semin Radiat Oncol. </span>2015;<span class="ref-vol">25</span>:181–8.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC4460567/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/26050588" ref="reftype=pubmed&amp;article-id=6367584&amp;issue-id=329202&amp;journal-id=294&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Semin+Radiat+Oncol&amp;title=Advances+in+the+Surgical+Management+of+Low-Grade+Glioma&amp;author=T+Hollon&amp;author=SL+Hervey-Jumper&amp;author=O+Sagher&amp;author=DA+Orringer&amp;volume=25&amp;publication_year=2015&amp;pages=181-8&amp;pmid=26050588&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=6367584&amp;issue-id=329202&amp;journal-id=294&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B37">37. <span class="element-citation">Rizzo D, Ruggiero A, Martini M, Rizzo V, Maurizi P, Riccardi R.  <span class="ref-journal">Molecular Biology in Pediatric High-Grade Glioma: Impact on Prognosis and Treatment.</span> Biomed Res Int; 2015.  <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC4584033/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/26448930" ref="reftype=pubmed&amp;article-id=6367584&amp;issue-id=329202&amp;journal-id=294&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?title=Molecular+Biology+in+Pediatric+High-Grade+Glioma:+Impact+on+Prognosis+and+Treatment&amp;author=D+Rizzo&amp;author=A+Ruggiero&amp;author=M+Martini&amp;author=V+Rizzo&amp;author=P+Maurizi&amp;publication_year=2015&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=6367584&amp;issue-id=329202&amp;journal-id=294&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B38">38. <span class="element-citation">Jiang T, Zhao B, Li XC, Wan JH. ARPP-19 promotes proliferation and metastasis of human glioma. <span><span class="ref-journal">Neuroreport. </span>2016;<span class="ref-vol">27</span>:960–6.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/27380244" ref="reftype=pubmed&amp;article-id=6367584&amp;issue-id=329202&amp;journal-id=294&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Neuroreport&amp;title=ARPP-19+promotes+proliferation+and+metastasis+of+human+glioma&amp;author=T+Jiang&amp;author=B+Zhao&amp;author=XC+Li&amp;author=JH+Wan&amp;volume=27&amp;publication_year=2016&amp;pages=960-6&amp;pmid=27380244&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=6367584&amp;issue-id=329202&amp;journal-id=294&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B39">39. <span class="element-citation">Su C, Liu C, Zhao L, Jiang J, Zhang J, Li S. et al. Amide Proton Transfer Imaging Allows Detection of Glioma Grades and Tumor Proliferation: Comparison with Ki-67 Expression and Proton MR Spectroscopy Imaging. <span><span class="ref-journal">American Journal of Neuroradiology. </span>2017;<span class="ref-vol">38</span>:1702–9.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC7963688/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/28729292" ref="reftype=pubmed&amp;article-id=6367584&amp;issue-id=329202&amp;journal-id=294&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=American+Journal+of+Neuroradiology&amp;title=Amide+Proton+Transfer+Imaging+Allows+Detection+of+Glioma+Grades+and+Tumor+Proliferation:+Comparison+with+Ki-67+Expression+and+Proton+MR+Spectroscopy+Imaging&amp;author=C+Su&amp;author=C+Liu&amp;author=L+Zhao&amp;author=J+Jiang&amp;author=J+Zhang&amp;volume=38&amp;publication_year=2017&amp;pages=1702-9&amp;pmid=28729292&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=6367584&amp;issue-id=329202&amp;journal-id=294&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B40">40. <span class="element-citation">Ozsolak F, Milos PM. RNA sequencing: advances, challenges and opportunities. <span><span class="ref-journal">Nat Rev Genet. </span>2011;<span class="ref-vol">12</span>:87–98.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC3031867/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/21191423" ref="reftype=pubmed&amp;article-id=6367584&amp;issue-id=329202&amp;journal-id=294&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nat+Rev+Genet&amp;title=RNA+sequencing:+advances,+challenges+and+opportunities&amp;author=F+Ozsolak&amp;author=PM+Milos&amp;volume=12&amp;publication_year=2011&amp;pages=87-98&amp;pmid=21191423&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=6367584&amp;issue-id=329202&amp;journal-id=294&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B41">41. <span class="element-citation">Mure H, Matsuzaki K, Kitazato KT, Mizobuchi Y, Kuwayama K, Kageji T. et al. Akt2 and Akt3 play a pivotal role in malignant gliomas. <span><span class="ref-journal">Neuro Oncol. </span>2010;<span class="ref-vol">12</span>:221–32.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2940586/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/20167810" ref="reftype=pubmed&amp;article-id=6367584&amp;issue-id=329202&amp;journal-id=294&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Neuro+Oncol&amp;title=Akt2+and+Akt3+play+a+pivotal+role+in+malignant+gliomas&amp;author=H+Mure&amp;author=K+Matsuzaki&amp;author=KT+Kitazato&amp;author=Y+Mizobuchi&amp;author=K+Kuwayama&amp;volume=12&amp;publication_year=2010&amp;pages=221-32&amp;pmid=20167810&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=6367584&amp;issue-id=329202&amp;journal-id=294&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B42">42. <span class="element-citation">Chautard E, Ouedraogo ZG, Biau J, Verrelle P. Role of Akt in human malignant glioma: from oncogenesis to tumor aggressiveness. <span><span class="ref-journal">J Neurooncol. </span>2014;<span class="ref-vol">117</span>:205–15.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/24477623" ref="reftype=pubmed&amp;article-id=6367584&amp;issue-id=329202&amp;journal-id=294&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Neurooncol&amp;title=Role+of+Akt+in+human+malignant+glioma:+from+oncogenesis+to+tumor+aggressiveness&amp;author=E+Chautard&amp;author=ZG+Ouedraogo&amp;author=J+Biau&amp;author=P+Verrelle&amp;volume=117&amp;publication_year=2014&amp;pages=205-15&amp;pmid=24477623&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=6367584&amp;issue-id=329202&amp;journal-id=294&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B43">43. <span class="element-citation">Zheng KB, Wang GY, Li CH, Shan XS, Liu HP. Knockdown of ILK inhibits glioma development via upregulation of E-cadherin and downregulation of cyclin D1. <span><span class="ref-journal">Oncol Rep. </span>2015;<span class="ref-vol">34</span>:272–8.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/25998224" ref="reftype=pubmed&amp;article-id=6367584&amp;issue-id=329202&amp;journal-id=294&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Oncol+Rep&amp;title=Knockdown+of+ILK+inhibits+glioma+development+via+upregulation+of+E-cadherin+and+downregulation+of+cyclin+D1&amp;author=KB+Zheng&amp;author=GY+Wang&amp;author=CH+Li&amp;author=XS+Shan&amp;author=HP+Liu&amp;volume=34&amp;publication_year=2015&amp;pages=272-8&amp;pmid=25998224&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=6367584&amp;issue-id=329202&amp;journal-id=294&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div></div></div></div><!--post-content--><div class="courtesy-note whole_rhythm small"><hr /><div class="half_rhythm">Articles from <span class="acknowledgment-journal-title">International Journal of Biological Sciences</span> are provided here courtesy of <strong>Ivyspring International Publisher</strong></div><hr /></div><div id="body-link-poppers"><span></span></div></div>
            
        </section>
    </article>
    <aside class="usa-width-one-fourth usa-layout-docs-sidenav pmc-sidebar">
         
  

<div class="scroller">

    
        <section>
                <h6>Other Formats</h6>
                <ul class="pmc-sidebar__formats">
                  <li class="pdf-link other_item"><a href="/pmc/articles/PMC6367584/pdf/ijbsv15p0533.pdf" class="int-view">PDF (1.8M)</a></li>
                </ul>
        </section>
    
    <section>
        <h6>Actions</h6>
        <ul class="pmc-sidebar__actions">
            <li>
                <button role="button" class="citation-button citation-dialog-trigger ctxp"
                        aria-label="Open dialog with citation text in different styles" data-ga-category="save_share" data-ga-action="cite" data-ga-label="open"
                        data-all-citations-url="/pmc/resources/citations/6367584/"
                        data-citation-style="nlm"
                        data-download-format-link="/pmc/resources/citations/6367584/export/"
                >
                    <span class="button-label">Cite</span>
                </button>
            </li>
            <li>
                
                    

<link type="text/css" href="ncbi-overlay-block/src/overlay-block.css">
<div class="collections-button-container" data-article-id="6367584" data-article-db="pmc">
  <button class="collections-button collections-dialog-trigger"
          aria-label="Save article in MyNCBI collections."
          data-ga-category="collections_button"
          data-ga-action="click"
          data-ga-label="collections_button"
          data-collections-open-dialog-enabled="false"
          data-collections-open-dialog-url="https://www.ncbi.nlm.nih.gov/account?back_url=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC6367584%2F%23open-collections-dialog"
          data-in-collections="false">
      <span class="button-label">Collections</span>
  </button>
  <div class="overlay" role="dialog">
  <div id="collections-action-dialog"
       class="dialog collections-dialog"
       aria-hidden="true">
    <div class="title">Add to Collections</div>
    <div class="collections-action-panel action-panel">
      


<form id="collections-action-dialog-form"
      class="collections-action-panel-form action-panel-content action-form action-panel-smaller-selectors"
      data-existing-collections-url="/pmc/list-existing-collections/"
      data-add-to-existing-collection-url="/pmc/add-to-existing-collection/"
      data-create-and-add-to-new-collection-url="/pmc/create-and-add-to-new-collection/"
      data-myncbi-max-collection-name-length="100"
      data-collections-root-url="https://www.ncbi.nlm.nih.gov/myncbi/collections/">

  <input type="hidden" name="csrfmiddlewaretoken" value="rNdaiLUo8DlrTbJ4cJDGYAdnQ1eOIhfHwS3bihuR3ww3geNBdIasID9A0m3VrDu5">

  

  <div class="choice-group" role="radiogroup">
    <ul class="radio-group-items">
      <li>
        <input type="radio"
               id="collections-action-dialog-new-aside "
               class="collections-new"
               name="collections"
               value="new"
               data-ga-category="collections_button"
               data-ga-action="click"
               data-ga-label="collections_radio_new">
        <label for="collections-action-dialog-new-aside ">Create a new collection</label>
      </li>
      <li>
        <input type="radio"
               id="collections-action-dialog-existing-aside "
               class="collections-existing"
               name="collections"
               value="existing"
               checked="true"
               data-ga-category="collections_button"
               data-ga-action="click"
               data-ga-label="collections_radio_existing">
        <label for="collections-action-dialog-existing-aside ">Add to an existing collection</label>
      </li>
    </ul>
  </div>

  <div class="controls-wrapper">
    <div class="action-panel-control-wrap new-collections-controls">
      <label for="collections-action-dialog-add-to-new" class="action-panel-label required-field-asterisk">
        Name your collection:
      </label>
      <input
        type="text"
        name="add-to-new-collection"
        id="collections-action-dialog-add-to-new"
        class="collections-action-add-to-new"
        pattern="[^&quot;&amp;=&lt;&gt;/]*" title="The following characters are not allowed in the Name field: &quot;&amp;=&lt;&gt;/"
        maxlength=""
        data-ga-category="collections_button"
        data-ga-action="create_collection"
        data-ga-label="non_favorties_collection">
      <div class="collections-new-name-too-long usa-input-error-message selection-validation-message">
        Name must be less than  characters
      </div>
    </div>
    <div class="action-panel-control-wrap existing-collections-controls">
      <label for="collections-action-dialog-add-to-existing" class="action-panel-label">
        Choose a collection:
      </label>
      <select id="collections-action-dialog-add-to-existing"
              class="action-panel-selector collections-action-add-to-existing"
              data-ga-category="collections_button"
              data-ga-action="select_collection"
              data-ga-label="($('.collections-action-add-to-existing').val() === 'Favorites') ? 'Favorites' : 'non_favorites_collection'">
      </select>
      <div class="collections-retry-load-on-error usa-input-error-message selection-validation-message">
        Unable to load your collection due to an error<br>
        <a href="#">Please try again</a>
      </div>
    </div>
  </div>

  <div class="action-panel-actions">
    <button class="action-panel-submit"
            type="submit"
            data-loading-label="Adding..."
            data-pinger-ignore
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="add">
      Add
    </button>
    <button class="action-panel-cancel"
            aria-label="Close 'Add to Collections' panel"
            ref="linksrc=close_collections_panel"
            aria-controls="collections-action-panel"
            aria-expanded="false"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="cancel">
      Cancel
    </button>
  </div>
</form>
    </div>
  </div>
</div>
</div>
                
            </li>

        </ul>
    </section>
    
        <section class="social-sharing">
            <h6>Share</h6>
            <ul class="pmc-sidebar__share">
                <li><a class="fa-stack fa-lg" target="_blank" rel="noopener noreferrer" role="button" href="https://twitter.com/intent/tweet?url=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC6367584%2F&amp;text=RRM2%20is%20a%20potential%20prognostic%20biomarker%20with%20functional%20significance%20in%20glioma" alt="Share on Twitter"><i class="fa fa-twitter fa-stack-1x">&#160;</i></a></li> 
<li><a class="fa-stack fa-lg" target="_blank" rel="noopener noreferrer" role="button" href="https://www.facebook.com/sharer/sharer.php?u=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC6367584%2F" alt="Share on Facebook"><i class="fa fa-facebook fa-stack-1x">&#160;</i></a></li>
                <li>
                    <div class="share-permalink">
                        <button class="trigger"  alt="Show article permalink" aria-expanded="false" aria-haspopup="true">
                            <i class="fa-stack fa-lg" >
                                <i class="fa fa-link fa-stack-1x">&nbsp;</i>
                            </i>
                        </button>
                        <div class="dropdown dropdown-container" hidden>
                              <div class="title">
                                Permalink
                              </div>
                              <div class="content">
                                  <input type="text" class="permalink-text" value="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6367584/" aria-label="Article permalink"><button class="permalink-copy-button usa-button-primary" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                                      <span class="button-title">Copy</span>
                                  </button>
                              </div>
                        </div>
                    </div>
                </li>
            </ul>
        </section>
    
    <section>
        <h6>RESOURCES</h6>
        <ul class="pmc-sidebar__resources">
        
            <li>
                <div class="usa-accordion">
                    <button
                            data-ga-category="resources_accordion"
                            data-ga-action="open_similar_articles"
                            data-ga-label="/pmc/articles/PMC6367584/"
                            class="usa-accordion-button"
                            aria-controls="similar-articles-accordion-aside"
                            aria-expanded="false"
                            data-action-open="open_similar_articles"
                            data-action-close="close_similar_articles"
                    >
                        Similar articles
                    </button>
                    <div
                            
                                data-source-url="/pmc/resources/similar-article-links/30745840/"
                            

                         class="usa-accordion-content pmc-sidebar__resources--citations" id="similar-articles-accordion-aside" aria-hidden="true">
                        
                    </div>
                </div>
            </li>
            <li>
                <div class="usa-accordion">
                    <button
                            data-ga-category="resources_accordion"
                            data-ga-action="open_cited_by"
                            data-ga-label="/pmc/articles/PMC6367584/"
                            class="usa-accordion-button"
                            aria-controls="cited-by-accordion-aside"
                            aria-expanded="false"
                            data-action-open="open_cited_by"
                            data-action-close="close_cited_by"
                    >
                        Cited by other articles
                    </button>
                    <div
                            
                                data-source-url="/pmc/resources/cited-by-links/30745840/"
                            
                            class="usa-accordion-content pmc-sidebar__resources--citations"
                            id="cited-by-accordion-aside"
                            aria-hidden="true"
                    >
                        
                    </div>
                </div>
            </li>
            <li>
                <div class="usa-accordion">
                    <button
                            data-ga-category="resources_accordion"
                            data-ga-action="open_NCBI_links"
                            data-ga-label="/pmc/articles/PMC6367584/"
                            class="usa-accordion-button"
                            aria-controls="links-accordion-aside"
                            aria-expanded="false"
                            data-action-open="open_NCBI_links"
                            data-action-close="close_NCBI_link"
                    >
                        Links to NCBI Databases
                    </button>
                    <div data-source-url="/pmc/resources/db-links/6367584/" class="usa-accordion-content" id="links-accordion-aside" aria-hidden="true"></div>
                </div>
            </li>

            
        
        </ul>
    </section>

 </div>

    </aside>
</main>

    <div class="overlay" role="dialog" aria-label="Citation Dialog">
  <div class="dialog citation-dialog">
    <button class="close-overlay" tabindex="1">[x]</button>
    <div class="title">Cite</div>
    <div class="citation-text-block">
  <div class="citation-text"></div>
  <div class="citation-actions">
    <button
      class="copy-button dialog-focus"
      data-ga-category="save_share"
      data-ga-action="cite"
      data-ga-label="copy"
      tabindex="2">
      Copy
    </button>

      <a href="#"
              class="export-button"
              data-ga-category="save_share"
              data-ga-action="cite"
              data-ga-label="download"
              title="Download a file for external citation management software"
              tabindex="3">
          <span class="title">Download .nbib</span>
          <span class="title-mobile">.nbib</span>
      </a>


    

<div class="citation-style-selector-wrapper">
  <label class="selector-label">Format:</label>
  <select aria-label="Format" class="citation-style-selector" tabindex="4" >
    
      <option data-style-url-name="ama"
              value="AMA"
              >
        AMA
      </option>
    
      <option data-style-url-name="apa"
              value="APA"
              >
        APA
      </option>
    
      <option data-style-url-name="mla"
              value="MLA"
              >
        MLA
      </option>
    
      <option data-style-url-name="nlm"
              value="NLM"
              selected="selected">
        NLM
      </option>
    
  </select>
</div>
  </div>
</div>
  </div>
</div>

     <!-- ========== BEGIN FOOTER ========== -->
 <footer>
      <section class="icon-section">
        <div id="icon-section-header" class="icon-section_header">Follow NCBI</div>
        <div class="grid-container container">
          <div class="icon-section_container">
            <a class="footer-icon" id="footer_twitter" href="https://twitter.com/ncbi" aria-label="Twitter"><svg
                data-name="Layer 1" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 300 300">
                <defs>
                  <style>
                    .cls-11 {
                      fill: #737373;
                    }
                  </style>
                </defs>
                <title>Twitter</title>
                <path class="cls-11"
                  d="M250.11,105.48c-7,3.14-13,3.25-19.27.14,8.12-4.86,8.49-8.27,11.43-17.46a78.8,78.8,0,0,1-25,9.55,39.35,39.35,0,0,0-67,35.85,111.6,111.6,0,0,1-81-41.08A39.37,39.37,0,0,0,81.47,145a39.08,39.08,0,0,1-17.8-4.92c0,.17,0,.33,0,.5a39.32,39.32,0,0,0,31.53,38.54,39.26,39.26,0,0,1-17.75.68,39.37,39.37,0,0,0,36.72,27.3A79.07,79.07,0,0,1,56,223.34,111.31,111.31,0,0,0,116.22,241c72.3,0,111.83-59.9,111.83-111.84,0-1.71,0-3.4-.1-5.09C235.62,118.54,244.84,113.37,250.11,105.48Z">
                </path>
              </svg></a>
            <a class="footer-icon" id="footer_facebook" href="https://www.facebook.com/ncbi.nlm" aria-label="Facebook"><svg
                data-name="Layer 1" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 300 300">
                <title>Facebook</title>
                <path class="cls-11"
                  d="M210.5,115.12H171.74V97.82c0-8.14,5.39-10,9.19-10h27.14V52l-39.32-.12c-35.66,0-42.42,26.68-42.42,43.77v19.48H99.09v36.32h27.24v109h45.41v-109h35Z">
                </path>
              </svg></a>
            <a class="footer-icon" id="footer_linkedin"
              href="https://www.linkedin.com/company/ncbinlm"
              aria-label="LinkedIn"><svg data-name="Layer 1" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 300 300">
                <title>LinkedIn</title>
                <path class="cls-11"
                  d="M101.64,243.37H57.79v-114h43.85Zm-22-131.54h-.26c-13.25,0-21.82-10.36-21.82-21.76,0-11.65,8.84-21.15,22.33-21.15S101.7,78.72,102,90.38C102,101.77,93.4,111.83,79.63,111.83Zm100.93,52.61A17.54,17.54,0,0,0,163,182v61.39H119.18s.51-105.23,0-114H163v13a54.33,54.33,0,0,1,34.54-12.66c26,0,44.39,18.8,44.39,55.29v58.35H198.1V182A17.54,17.54,0,0,0,180.56,164.44Z">
                </path>
              </svg></a>
            <a class="footer-icon" id="footer_github" href="https://github.com/ncbi" aria-label="GitHub"><svg
                data-name="Layer 1" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 300 300">
                <defs>
                  <style>
                    .cls-11,
                    .cls-12 {
                      fill: #737373;
                    }

                    .cls-11 {
                      fill-rule: evenodd;
                    }
                  </style>
                </defs>
                <title>GitHub</title>
                <path class="cls-11"
                  d="M151.36,47.28a105.76,105.76,0,0,0-33.43,206.1c5.28,1,7.22-2.3,7.22-5.09,0-2.52-.09-10.85-.14-19.69-29.42,6.4-35.63-12.48-35.63-12.48-4.81-12.22-11.74-15.47-11.74-15.47-9.59-6.56.73-6.43.73-6.43,10.61.75,16.21,10.9,16.21,10.9,9.43,16.17,24.73,11.49,30.77,8.79,1-6.83,3.69-11.5,6.71-14.14C108.57,197.1,83.88,188,83.88,147.51a40.92,40.92,0,0,1,10.9-28.39c-1.1-2.66-4.72-13.42,1-28,0,0,8.88-2.84,29.09,10.84a100.26,100.26,0,0,1,53,0C198,88.3,206.9,91.14,206.9,91.14c5.76,14.56,2.14,25.32,1,28a40.87,40.87,0,0,1,10.89,28.39c0,40.62-24.74,49.56-48.29,52.18,3.79,3.28,7.17,9.71,7.17,19.58,0,14.15-.12,25.54-.12,29,0,2.82,1.9,6.11,7.26,5.07A105.76,105.76,0,0,0,151.36,47.28Z">
                </path>
                <path class="cls-12"
                  d="M85.66,199.12c-.23.52-1.06.68-1.81.32s-1.2-1.06-.95-1.59,1.06-.69,1.82-.33,1.21,1.07.94,1.6Zm-1.3-1">
                </path>
                <path class="cls-12"
                  d="M90,203.89c-.51.47-1.49.25-2.16-.49a1.61,1.61,0,0,1-.31-2.19c.52-.47,1.47-.25,2.17.49s.82,1.72.3,2.19Zm-1-1.08">
                </path>
                <path class="cls-12"
                  d="M94.12,210c-.65.46-1.71,0-2.37-.91s-.64-2.07,0-2.52,1.7,0,2.36.89.65,2.08,0,2.54Zm0,0"></path>
                <path class="cls-12"
                  d="M99.83,215.87c-.58.64-1.82.47-2.72-.41s-1.18-2.06-.6-2.7,1.83-.46,2.74.41,1.2,2.07.58,2.7Zm0,0">
                </path>
                <path class="cls-12"
                  d="M107.71,219.29c-.26.82-1.45,1.2-2.64.85s-2-1.34-1.74-2.17,1.44-1.23,2.65-.85,2,1.32,1.73,2.17Zm0,0">
                </path>
                <path class="cls-12"
                  d="M116.36,219.92c0,.87-1,1.59-2.24,1.61s-2.29-.68-2.3-1.54,1-1.59,2.26-1.61,2.28.67,2.28,1.54Zm0,0">
                </path>
                <path class="cls-12"
                  d="M124.42,218.55c.15.85-.73,1.72-2,1.95s-2.37-.3-2.52-1.14.73-1.75,2-2,2.37.29,2.53,1.16Zm0,0"></path>
              </svg></a>
            <a class="footer-icon" id="footer_blog" href="https://ncbiinsights.ncbi.nlm.nih.gov/" aria-label="Blog">
              <svg id="Layer_1" data-name="Layer 1" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 40 40"><defs><style>.cls-1{fill:#737373;}</style></defs><path class="cls-1" d="M14,30a4,4,0,1,1-4-4,4,4,0,0,1,4,4Zm11,3A19,19,0,0,0,7.05,15a1,1,0,0,0-1,1v3a1,1,0,0,0,.93,1A14,14,0,0,1,20,33.07,1,1,0,0,0,21,34h3a1,1,0,0,0,1-1Zm9,0A28,28,0,0,0,7,6,1,1,0,0,0,6,7v3a1,1,0,0,0,1,1A23,23,0,0,1,29,33a1,1,0,0,0,1,1h3A1,1,0,0,0,34,33Z"/></svg>
            </a>
          </div>
        </div>
      </section>

      <section class="container-fluid bg-primary">
        <div class="container pt-5">
          <div class="row mt-3">
            <div class="col-lg-3 col-12">
              <p><a class="text-white" href="https://www.nlm.nih.gov/socialmedia/index.html">Connect with NLM</a></p>
              <ul class="list-inline social_media">
                <li class="list-inline-item"><a href="https://twitter.com/NLM_NIH" aria-label="Twitter"
                    target="_blank" rel="noopener noreferrer"><svg version="1.1" xmlns="http://www.w3.org/2000/svg"
                      xmlns:xlink="http://www.w3.org/1999/xlink" x="0px" y="0px" viewBox="0 0 249 249"
                      style="enable-background:new 0 0 249 249;" xml:space="preserve">
                      <style type="text/css">
                        .st20 {
                          fill: #FFFFFF;
                        }

                        .st30 {
                          fill: none;
                          stroke: #FFFFFF;
                          stroke-width: 8;
                          stroke-miterlimit: 10;
                        }
                      </style>
                      <title>SM-Twitter</title>
                      <g>
                        <g>
                          <g>
                            <path class="st20" d="M192.9,88.1c-5,2.2-9.2,2.3-13.6,0.1c5.7-3.4,6-5.8,8.1-12.3c-5.4,3.2-11.4,5.5-17.6,6.7
                                                c-10.5-11.2-28.1-11.7-39.2-1.2c-7.2,6.8-10.2,16.9-8,26.5c-22.3-1.1-43.1-11.7-57.2-29C58,91.6,61.8,107.9,74,116
                                                c-4.4-0.1-8.7-1.3-12.6-3.4c0,0.1,0,0.2,0,0.4c0,13.2,9.3,24.6,22.3,27.2c-4.1,1.1-8.4,1.3-12.5,0.5c3.6,11.3,14,19,25.9,19.3
                                                c-11.6,9.1-26.4,13.2-41.1,11.5c12.7,8.1,27.4,12.5,42.5,12.5c51,0,78.9-42.2,78.9-78.9c0-1.2,0-2.4-0.1-3.6
                                                C182.7,97.4,189.2,93.7,192.9,88.1z"></path>
                          </g>
                        </g>
                        <circle class="st30" cx="124.4" cy="128.8" r="108.2"></circle>
                      </g>
                    </svg></a></li>
                <li class="list-inline-item"><a href="https://www.facebook.com/nationallibraryofmedicine"
                    aria-label="Facebook" rel="noopener noreferrer" target="_blank">
                    <svg version="1.1" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink" x="0px"
                      y="0px" viewBox="0 0 249 249" style="enable-background:new 0 0 249 249;" xml:space="preserve">
                      <style type="text/css">
                        .st10 {
                          fill: #FFFFFF;
                        }

                        .st110 {
                          fill: none;
                          stroke: #FFFFFF;
                          stroke-width: 8;
                          stroke-miterlimit: 10;
                        }
                      </style>
                      <title>SM-Facebook</title>
                      <g>
                        <g>
                          <path class="st10" d="M159,99.1h-24V88.4c0-5,3.3-6.2,5.7-6.2h16.8V60l-24.4-0.1c-22.1,0-26.2,16.5-26.2,27.1v12.1H90v22.5h16.9
                                                      v67.5H135v-67.5h21.7L159,99.1z"></path>
                        </g>
                      </g>
                      <circle class="st110" cx="123.6" cy="123.2" r="108.2"></circle>
                    </svg>
                  </a></li>
                <li class="list-inline-item"><a href="https://www.youtube.com/user/NLMNIH" aria-label="Youtube"
                    target="_blank" rel="noopener noreferrer"><svg version="1.1" xmlns="http://www.w3.org/2000/svg"
                      xmlns:xlink="http://www.w3.org/1999/xlink" x="0px" y="0px" viewBox="0 0 249 249"
                      style="enable-background:new 0 0 249 249;" xml:space="preserve">
                      <title>SM-Youtube</title>
                      <style type="text/css">
                        .st4 {
                          fill: none;
                          stroke: #FFFFFF;
                          stroke-width: 8;
                          stroke-miterlimit: 10;
                        }

                        .st5 {
                          fill: #FFFFFF;
                        }
                      </style>
                      <circle class="st4" cx="124.2" cy="123.4" r="108.2"></circle>
                      <g transform="translate(0,-952.36218)">
                        <path class="st5"
                          d="M88.4,1037.4c-10.4,0-18.7,8.3-18.7,18.7v40.1c0,10.4,8.3,18.7,18.7,18.7h72.1c10.4,0,18.7-8.3,18.7-18.7
                                            v-40.1c0-10.4-8.3-18.7-18.7-18.7H88.4z M115.2,1058.8l29.4,17.4l-29.4,17.4V1058.8z"></path>
                      </g>
                    </svg></a></li>
              </ul>
            </div>
            <div class="col-lg-3 col-12">
              <p class="address_footer text-white">National Library of Medicine<br>
                <a href="https://www.google.com/maps/place/8600+Rockville+Pike,+Bethesda,+MD+20894/@38.9959508,-77.101021,17z/data=!3m1!4b1!4m5!3m4!1s0x89b7c95e25765ddb:0x19156f88b27635b8!8m2!3d38.9959508!4d-77.0988323"
                  class="text-white" target="_blank" rel="noopener noreferrer">8600 Rockville Pike<br>
                  Bethesda, MD 20894</a></p>
            </div>
            <div class="col-lg-3 col-12 centered-lg">
              <p><a href="https://www.nlm.nih.gov/web_policies.html" class="text-white">Web Policies</a><br>
                <a href="https://www.nih.gov/institutes-nih/nih-office-director/office-communications-public-liaison/freedom-information-act-office"
                  class="text-white">FOIA</a><br>
                <a href="https://www.hhs.gov/vulnerability-disclosure-policy/index.html" class="text-white" id="vdp">HHS Vulnerability Disclosure</a></p>
            </div>
            <div class="col-lg-3 col-12 centered-lg">
              <p><a class="supportLink text-white" href="https://support.nlm.nih.gov/">Help</a><br>
                <a href="https://www.nlm.nih.gov/accessibility.html" class="text-white">Accessibility</a><br>
                <a href="https://www.nlm.nih.gov/careers/careers.html" class="text-white">Careers</a></p>
            </div>
          </div>
          <div class="row">
            <div class="col-lg-12 centered-lg">
              <nav class="bottom-links">
                <ul class="mt-3">
                  <li>
                    <a class="text-white" href="//www.nlm.nih.gov/">NLM</a>
                  </li>
                  <li>
                    <a class="text-white"
                  href="https://www.nih.gov/">NIH</a>
                  </li>
                  <li>
                    <a class="text-white" href="https://www.hhs.gov/">HHS</a>
                  </li>
                  <li>
                    <a
                  class="text-white" href="https://www.usa.gov/">USA.gov</a>
                  </li>
                </ul>
              </nav>
            </div>
          </div>
        </div>
      </section>
    </footer>
 <!-- ========== END FOOTER ========== -->
  <!-- javascript to inject NWDS meta tags. Note: value of nwds_version is updated by "npm version" command -->
 
  <script type="text/javascript">
    var nwds_version = "1.1.9-2";

    var meta_nwds_ver = document.createElement('meta');
    meta_nwds_ver.name = 'ncbi_nwds_ver';
    meta_nwds_ver.content = nwds_version;
    document.getElementsByTagName('head')[0].appendChild(meta_nwds_ver);

    var meta_nwds = document.createElement('meta');
    meta_nwds.name = 'ncbi_nwds';
    meta_nwds.content = 'yes';
    document.getElementsByTagName('head')[0].appendChild(meta_nwds);

	var alertsUrl = "/core/alerts/alerts.js";
	if (typeof ncbiBaseUrl !== 'undefined') {
		alertsUrl = ncbiBaseUrl + alertsUrl;
	}
  </script>



  
    <!-- JavaScript -->
    <script src="/pmc/static/CACHE/js/output.0f72d6a64937.js"></script>
  
  
    <script src="https://code.jquery.com/jquery-3.5.0.min.js"
          integrity="sha256-xNzN2a4ltkB44Mc/Jz3pT4iU1cmeR0FkXs4pru/JxaQ="
          crossorigin="anonymous">
    </script>
    <script>
        var fallbackJquery = "/pmc/static/base/js/jquery-3.5.0.min.js";
        window.jQuery || document.write("<script src=" + fallbackJquery + ">\x3C/script>")
    </script>
  

  <script src="/pmc/static/CACHE/js/output.a212a9fcf845.js"></script>
<script src="/pmc/static/CACHE/js/output.7999321d1aac.js"></script>
<script src="/pmc/static/CACHE/js/output.7ca436b2ea51.js"></script>
<script src="/pmc/static/CACHE/js/output.f8422046fbe0.js"></script>
<script src="/pmc/static/CACHE/js/output.ff40c7d85ff8.js"></script>
<script src="/pmc/static/CACHE/js/output.a6a84a0ad361.js"></script>

<script type="text/javascript" src="/pmc/static/bundles/base/base.038d36e4e31104b40a19.js" ></script>

    <script type="text/javascript">
        if(typeof jQuery !=='undefined') {
            jQuery.migrateMute = true;
        }
    </script>
    <script type="text/javascript" src="https://code.jquery.com/jquery-migrate-1.4.1.js"></script>
    <script type="text/javascript" src="/core/jig/1.15.2/js/jig.nojquery.min.js">//</script><script type="text/javascript" src="/corehtml/pmc/js/common.min.js?_=3.18">//</script><script type="text/javascript" src="/corehtml/pmc/js/NcbiTagServer.min.js?_=3.18">//</script><script type="text/javascript" src="/corehtml/pmc/js/crb.min.js?_=3.18">//</script><script type="text/javascript" src="/corehtml/pmc/js/jactions.min.js?_=3.18">//</script><script type="text/javascript">window.name="mainwindow";</script>

    <script type="text/javascript">var exports = {};</script>
    <script src="/pmc/static/CACHE/js/output.340a3b9cce7f.js"></script>
<script src="/pmc/static/CACHE/js/output.228f96f3298e.js"></script>
    <script type="text/javascript" src="/pmc/static/bundles/article/article.b7dd20e527283dd68f45.js" ></script>
    <script type="text/javascript">
        window.ncbi.pmc.articlePage.init({ pageURL: '/pmc/articles/PMC6367584/', citeCookieName: 'pmc-cf'});
    </script>


  
  
  <script  type="text/javascript" src="https://www.ncbi.nlm.nih.gov/core/pinger/pinger.js"> </script>


  
      
  

</body>
</html>
